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Abstract
Fluid and HCO3− secretion is a vital function of all epithelia and is required for the survival of the
tissue. Aberrant fluid and HCO3− secretion is associated with many epithelial diseases, such as
cystic fibrosis, pancreatitis, Sjögren’s syndrome and other epithelial inflammatory and
autoimmune diseases. Significant progress has been made over the last 20 years in our
understanding of epithelial fluid and HCO3− secretion, in particular by secretory glands. Fluid and
HCO3− secretion by secretory glands is a two step process. Acinar cells secrete isotonic fluid in
which the major salt is NaCl. Subsequently, the duct modifies the volume and electrolyte
composition of the fluid to absorb the Cl− and secrete HCO3−. The relative volume secreted by
acinar and duct cells and modification of electrolyte composition of the secreted fluids varies
among secretory glands to meet their physiological functions. In the pancreas, acinar cells secrete
small amount of NaCl-rich fluid, while the duct absorbs the Cl− and secretes HCO3− and the bulk
of the fluid in the pancreatic juice. Fluid secretion appears to be driven by active HCO3− secretion.
In the salivary glands, acinar cells secrete the bulk of the fluid in the saliva that contains high
concentrations of Na+ and Cl− and fluid secretion is mediated by active Cl− secretion. The salivary
glands duct absorbs both the Na+ and Cl− and secretes K+ and HCO3−. In this review, we focus on
the molecular mechanism of fluid and HCO3− secretion by the pancreas and salivary glands, to
highlight the similarities of the fundamental mechanisms of acinar and duct cell functions, and
point the differences to meet glands specific secretions.
I. INTRODUCTION
Bicarbonate (HCO3−) is an indispensible ion in secreted fluids, including the pancreatic
juice and saliva. Among other functions, HCO3− is the biological pH buffer that guards
against toxic intracellular and extracellular fluctuations in pH (365). As a chaotropic ion,
HCO3− facilitates solubilization of macromolecules (like digestive enzymes and mucins) in
biological fluids and stimulates mucin secretion (45, 145, 410). HCO3− secreted by the
exocrine pancreas neutralizes gastric acid and provides an optimal pH environment for
digestive enzymes function in the duodenum (237). HCO3− secretion into the oral cavity
protects against enamel erosion by acidic pH (192). Indeed, recent progress in epithelial
biology indicates that aberrant HCO3− transport has a fundamental role in human
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pathophysiology (346, 347). For example, in cystic fibrosis (CF) abnormal HCO3− secretion
leads to altered mucin hydration and solubilization (348), resulting in thick mucus that
frequently blocks ductal structures of the internal organs. Therefore, altered HCO3−
secretion is associated with a wide spectrum of diseases and disorders of epithelial tissues
including respiratory, gastrointestinal, and genitourinary systems (61, 284, 346, 347, 432).
At pH 7.4 and 5% CO2, the HCO3− equilibrium concentration is approximately 25 mM.
Several bodily fluids have higher HCO3− concentration, and among them the pancreatic
juice contains the highest concentration. In humans and several other species, such as dogs,
cats, and guinea pigs, HCO3− concentration in the juice secreted by the stimulated pancreas
can be higher than 140 mM (86, 237). This remarkable transport feat attracts considerable
attention to pancreatic HCO3− secretory mechanism, which is the model of choice to gain
insight into the mechanism of epithelial fluid and HCO3− transport. How exocrine glands
secrete copious amount of fluid and HCO3− has long been a puzzle. The discovery of acidic
pancreatic juice in patients with CF was a milestone in understanding the physiological
mechanisms of pancreatic HCO3− secretion (191). In addition, significant progress has been
made during the last 20 years with the identification of the molecular nature of many
exocrine glands ion channels and transporters, including the cystic fibrosis transmembrane
conductance regulator (CFTR) (199), the Na+-HCO3− co-transporter NBCe1-B (also known
an pNBC1) (1) and the SLC26 transporters (91, 314). Regulation and coordination of
exocrine HCO3− secretion is being defined with understanding the role of regulatory
proteins, such as PSD95/discs large/ZO-1 (PDZ)-based adaptor proteins, with-no-lysine
(WNK) kinases, the SPAK/OSR1 kinases and of the inositol-1,4,5-triphosphate (IP3)
receptor binding protein released with IP3 (IRBIT). However, we have just begun to uncover
how the transporting proteins are organized into complexes that function in concert in the
luminal (apical) and basolateral membranes and how the high concentration of HCO3− in
formed and maintained in the luminal space of exocrine glands.
Another cardinal aspect of exocrine gland function is fluid secretion. While HCO3−
secretion is mostly carried out by the gland ducts, the bulk of fluid secretion can be by the
duct, as in the exocrine pancreas (237, 404), or by acinar cells, as in the salivary glands
(274, 368). While the ionic bases of fluid secretion by the duct are poorly understood, the
fundamental mechanism of acinar cell fluid secretion is fairly well characterized. Early
mechanistic work defined the basic transport mechanisms at the BLM and LM (331). More
recent work relied on gene deletion in mice (50, 369), which confirmed the basic
mechanism, but also resulted in unexpected surprises as to the diversity and function of
transporter isoforms.
This review is aimed at consolidating the current knowledge of exocrine glands fluid and
HCO3− secretion. Since it is understood best, fluid secretion by salivary glands will be
emphasized as an example for the mechanism of fluid secretion by acinar cells. Ductal
function will be discussed in relation to the molecular mechanism of pancreatic HCO3−
secretion with an attempt to explain how the pancreatic juice can accumulate 140 mM
HCO3−, a concentration that is more than five times higher than that found in plasma. We
will also briefly discuss fluid and HCO3− transport by salivary gland ducts to demonstrate
adaptation and alteration of the basic mechanism to meat tissue specific demands.
II. GENERAL CONSIDERATIONS
A. Overview
When Bayliss and Starling described the discovery of the pancreatic secretagogue secretin,
they also noticed that the exocrine pancreas secretes alkaline fluids (25). At the time, they
assumed that carbonate is responsible for the strong alkalinity of the pancreatic juice. Later,
Lee et al. Page 2
Physiol Rev. Author manuscript; available in PMC 2013 May 30.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
with better understanding of the carbonate/HCO3−/CO2 buffer systems (156), it became
clear that the exocrine pancreas secretes fluid in which the dominant anion is HCO3− and
HCO3− secretion is coupled to fluid secretion (46, 87, 143). Exocrine glands secrete
macromolecules like digestive enzymes and mucins immersed in a HCO3−-rich fluid.
Exocrine glands secretion is a two step process (412). The digestive enzymes are
synthesized and secreted by the acinar cells. Depending on the gland, acinar cells also
secrete a small (pancreas) or a large (salivary) volume of isotonic, plasma-like, NaCl-rich
fluid (237, 274). The fluid secreted by acinar cells deliver the macromolecules to the duct.
The duct modifies the ionic composition of the fluid along the ductal tree to absorb most of
the Cl− and secrete the bulk of the HCO3−. The pancreatic duct also secretes most of the
fluid in the pancreatic juice (14, 404) and the salivary duct absorbs the Na+ and secret K+ to
form the final saliva (368). Hence, the ductal tree has several functions, providing a
structural framework for acinar and endocrine tissues, secreting fluid that acts as a vehicle
for the transport of macromolecules out of the glands, and secreting HCO3− to neutralize
acid and provide optimal pH environment for the secreted macromolecules at their
destination (14, 44).
B. Morphology
Below, we describe the anatomy of the pancreas as an example of an exocrine gland.
However, the anatomy of other exocrine glands (like the salivary, lacrimal and mammary) is
similarly organized. The pancreas is a complex endocrine-exocrine organ, with each part
developed from the ventral and dorsal surfaces of the primitive foregut, respectively. Similar
to other exocrine glands, the exocrine pancreas is composed of two major cell types, the
acinar and duct cells. In humans and most other mammals, acinar cells comprise the major
mass of the pancreas and duct cells comprise only about 10% of the cells in number and 5%
of the total pancreatic gland weight (44). The terminal portion of the ductal tree leading
directly from the acinus is called intercalated duct (Fig. 1).
The acinar cells are the classical model for polarized epithelial cells, having a typical
morphology with extensive rough ER at the basal pole and smooth ER at the apical pole.
The nucleus is close to the basal pole and is followed by the Golgi apparatus, the secretory
granules that are packed at the apical pole, and the luminal membrane (271). The polarity is
extended to other intracellular organelles and to single proteins. A good example is the Ca2+
signaling proteins. These proteins are organized as Ca2+ signaling complexes next or at the
tight junctions, with polarized expression of Ca2+ pumps (239, 474), Ca2+ channels (240), G
protein-coupled receptors (392) and regulatory proteins (163), that are essential for
generating the localized Ca2+ signal and the propagated Ca2+ waves (208, 337).
The acinar lobule terminates and the duct starts with the centroacinar cells, which have
several ductal characteristics, are regarded as the terminal cells of the ductal tree and
connect the acinar and duct cells (237). The duct has several segments based on size and
location. Although here we emphasize the secretory (serous) duct cells, it is important to
note that the duct has several cell types, including mucosal and ciliated cells. The cellular
heterogeneity is found in all segments of the ductal tree. Small intercalated ducts join
together and sequentially form the intralobular, interlobular, and interlobar duct segments
(Fig. 1). In humans, the interlobar ducts join to form the main pancreatic duct (duct of
Wirsung), which shares a duodenal opening with the common bile duct at the Ampulla of
Vater. Most individuals have one main pancreatic duct, but some have an additional
accessory pancreatic duct, the Duct of Santorini (34). In rodents, a number of interlobular or
interlobar ducts open directly into the common pancreaticobiliary duct without forming a
main duct (237). Much attention is devoted in recent years to developmental aspects of the
duct, since the duct contains the glandular stem cells that are necessary for development and
gland repair after injury (195, 219, 248).
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The intercalated and small intralobular ducts are the major sites of HCO3− secretion in the
human pancreas and salivary glands, whereas in rodents the interlobular duct secretes the
bulk of the fluid and HCO3− (259). The HCO3−-secreting portion of these ducts is lined by
the principal cells. These cells contain a relatively small amount of cellular organelles
required for protein secretion, such as rough endoplasmic reticulum (RER), Golgi
complexes and secretory vesicles. Instead, they are rich with mitochondria to satisfy the
energy demand of transcellular HCO3− and fluid secretion. The luminal membrane of the
principal cells is endowed with extensive microvilli. The lateral membrane is interdigitated
and linked by tight and adherent junctions and desmosomes. In the larger ducts the principal
cells become columnar and the duct contains goblet cells, which are specialized in mucin
secretion (44, 257).
C. Electrolyte Composition of the Secreted Fluids
The human pancreas secretes 1–2 L of pancreatic juice per day. The pancreatic juice is a
alkaline, isotonic fluid. The acini secrete isotonic, plasma-like fluid. The pancreatic duct
does not absorb the Na+, but absorbs most of the Cl− and secret HCO3−. The human
pancreatic duct can secrete a fluid containing 140 mM HCO3− (86). However, the HCO3−
concentration in mouse and rat pancreatic juice is 50–70 mM (386). The HCO3− content in
the juice increases with increased flow rate. The peak HCO3− content is reached at 30–50%
of maximal flow rate. The reciprocal Cl− absorption and HCO3− secretion results in isotonic
osmolality at all flow rates (46, 358, 386). The cation composition of the juice is nearly
constant, 140 mM Na+ and 10–15 mM K+, regardless of flow rate. Human juice also
contains 1–2 mM Ca2+ and a small amount of Mg2+, Zn2+, PO43−, and SO42−.
Humans secrete about 1 L saliva per day. The resting secretion is dominated by the
submandibular and sublingual glands, whereas the stimulated secretion is mainly by the
parotid gland (369). As is the case in the pancreas, electrolyte composition of the saliva
varies with flow rate and among species. Unlike the pancreas, most salivary fluid is secreted
by the serous acinar cells, which secrete isotonic, NaCl-rich fluid. The primary fluid in the
rat and cat contains 145–160 mM Na+, 5–10 K+, 120–130 Cl− and pH of about 7.5 (382).
The salivary gland ducts express the epithelial Na+ channel ENaC (65) and absorbs most of
the Na+ and Cl− from the primary saliva while secreting K+ and HCO3− to generate the final
saliva. The cholinergic stimulated and Ca2+-dependent saliva in the rat and mouse at steady
state contains 2 mM Na+, 135 mM K+, 55 mM HCO−3 and 78 mM Cl− at a transepithelial
potential of −11 mV (66, 462). Interestingly, the β-adrenergic stimulated small volume of
saliva contains as much as 140 mM HCO3− and as little as 20 mM Cl− (382, 462). This
indicates that cholinergic and β-adrenergic stimulation use different pathways to stimulate
fluid and electrolyte secretion.
III. HORMONAL CONTROL OF FLUID AND HCO3− SECRETION
A. Overview
Like any physiological system, the function of exocrine glands is controlled by multiple
neurohomoral inputs that form intricate regulatory pathways. Here we focus our discussion
on the exocrine pancreas, although for the most part similar mechanisms operate in the
salivary glands. The fundamental similarities between the two tissues are that fluid secretion
by acinar cells is regulated by Ca2+-mobilizing agonist (274, 334, 337) and fluid and HCO3−
secretion by duct cells is largely regulated by cAMP generating receptors (237, 265). The
most obvious difference that is outside the topic of this review is in enzyme secretion that is
Ca2+-activated in the pancreas, but cAMP-activated in the salivary glands. In addition,
sympathetic inputs are central in the function of salivary glands, but do not play a role in the
function of the exocrine pancreas.
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Neurohumoral control of pancreatic fluid and electrolyte secretion was first proposed in the
early 20th century (25, 328). Knowledge accumulated over the past 100 years has revealed
that regulation of pancreatic secretion is highly complex with multiple stimulatory and
inhibitory inputs (398) and varies greatly among species. Basal secretion in rat and mouse is
significant, while basal secretion in dog and possibly human is very small, amounting to less
than 2% of the HCO3− and 10% of the digestive enzymes secreted during maximal
stimulation (73). HCO3− salvage mechanisms in the large pancreatic duct contribute to the
low basal HCO3− output (234, 250). Pancreatic enzyme and HCO3− secretion increases in
response to a meal. Control of pancreatic secretion is divided into cephalic, gastric, and
intestinal phases (44). The intestinal phase is the most important and commences with the
passage of chyme into the proximal duodenum. The pancreatic acini and duct express
receptors for a battery of hormones and neurotransmitters. The major receptors in acini are
for the hormones cholecystokinin (CCK) and bombesin and the neurotransmitter
acetylcholine. The hormone secretin, secreted by cells in the upper duodenum, and
cholinergic vagal output via an enteropancreatic vagovagal reflex are the two principal
receptors controlling ductal fluid and HCO3− secretion. Secretin and cholecystokinin (CCK)
are released by distant organs and require high affinity receptors because they reach the
pancreas via the bloodstream (237). In addition to these classical hormones, a large number
of humoral agents are released by the pancreas to modulate its function. Cells in the islets of
Langerhans release insulin, somatostatin, and several other peptide hormones (243), and
paracrine agonists released from pancreatic acinar and duct cells, such as purines,
prostaglandins and activated trypsin, regulate duct cell function in physiological and
pathological states.
B. Endocrine and Paracrine Control
Cholecystokinin (CCK)—Circulating CCK released from the small intestines is a major
stimulator of acinar cells enzyme and fluid secretion. This has been amply demonstrated in
several rodent species. CCK acting through an increase in cytoplasmic Ca2+ prominently
stimulates Ca2+-dependent exocytosis. However, the relevance of CCK-mediated action in
human acinar cells has been questioned by several studies, suggested that the effect of CCK
is mostly mediated by stimulation of the intestinal vagal afferent fibers (319). This was
based on the claim that the human pancreas does not express CCK-A receptors (187, 188,
278). However, this problem was resolved recently with the demonstration of CCK-evoked
Ca2+ signals and exocytosis in isolated human acinar cells (286). The endogenously released
CCK is heterogeneous and consists of multiple forms including CCK-58, CCK-33, CCK-8
(101). Although the exact role of each isoform is not known and in isolated acini they have
similar activity (69), there is evidence for differences in their function in vivo (453).
CCK also acts on the pancreatic duct to affect fluid secretions, but its effect varies among
species. In humans, the infusion of CCK alone weakly stimulates fluid secretion, but it
greatly potentiates the effects of secretin (460). This suggests prominent synergism between
the Ca2+ and cAMP systems in stimulated ductal secretion. This is discussed in more detail
in another section of this review.
Secretin—The entry of acidic chyme into the duodenum evokes the release of secretin
from neuroendocrine cells in the duodenal mucosa. Intraduodenal pH below 4.5 is a prime
stimulus for secretin release (37, 58). Secretin acts mainly on the duct by increasing cAMP
to stimulate ductal fluid and HCO3− secretion. That secretin is the principal hormone in
postprandial fluid and HCO3− secretion is evident from 1) a rise in plasma secretin after a
meal (58, 341), 2) a linear relationship between the rise in plasma secretin and HCO3−
output (380) and 3) inhibition of postprandial pancreatic HCO3− secretion by serum anti-
secretin (57). Plasma secretin in response to a meal reaches only pM levels, which is
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sufficient to stimulate modest fluid and HCO3− secretion in all species. CCK and vagal
stimulation further potentiates the secretin-stimulated secretion (134, 216, 460).
Purines—Purinergic receptors (P2Rs) are classified into metabotropic P2Y and ionotropic
P2X receptors and transduce their signal by increasing cytoplasmic Ca2+. Pancreatic acini
store and secret ATP but do not appear to express P2Rs (304). ATP released by acini acts on
the duct, which expresses multiple P2YRs and P2XRs both at the apical and basolateral
membranes (252). Stimulation of P2Rs in the isolated pancreatic ducts from several species
induces fluid secretion and activates membrane transporters that enhance HCO3− secretion
(291, 304, 476). However, P2Rs regulation can be quite complicated, for example
stimulations of the apical and basolateral P2Rs have opposite effect on guinea pig ductal
secretion (176). Possible sources of purinergic ligands include release by nerve terminals at
the basolateral space, release of purines stored in zymogene granules of acinar cells, and
efflux by ductal ATP transporters (302, 304). Although the purinergic system likely plays a
role in the regulation of pancreatic ductal secretion under physiological and pathological
states, its specific role in humans yet to be demonstrated.
Other humoral mediators secreted by islets, the gastrointestinal tract and the intrapancreatic
nervous system can also modulate the function of the exocrine pancreas, although their exact
physiological function remained to be elucidated (see (237) for further details).
C. Neuronal Control
Pancreatic secretion is controlled by the enteric nervous system, which is comprised of a
gut-brain axis and an intrapancreatic system. The intrapancreatic nervous system comprises
of interconnecting plexus of ganglia and postganglionic fibers lying in the intralobular
connective tissues, blood vessels, and occasionally in the neuronal trunk (207, 217). It is
supplied by preganglionic parasympathetic (vagal) fibers, postganglionic sympathetic
(splanchic) fibers, and possibly other fibers that emanate directly from the gut wall. Nerve
fibers travel through the lamina propria of the acini and the duct, with nerve terminals
located in close proximity to the basal membrane without forming synapses (257, 418).
The major neurotransmitter acting on acinar and duct cells is acetylcholine secreted by vagal
parasympathetic fibers. The acini and duct express M1 and M3 cholinergic receptors,
although the M3 is the main receptor type (113) and acts by increasing cytoplasmic Ca2+
([Ca2+]i) (208). Parasympathetic nerve terminals contain additional neurotransmitters,
including vasoactive intestinal peptide (VIP) and ATP (217, 303). The effects of vagal
stimulation on pancreatic fluid secretion show species-specific pattern and are quite
variable. Vagal stimulation in pigs and guinea pigs causes VIP-stimulated fluid and HCO3−
secretion (162, 217). In humans, cholinergic stimulation results in enzyme secretion by
acinar cells and enhances the secretin-stimulated ductal secretion, likely by the Ca2+-cAMP
synergy. The synergism between the Ca2+ and cAMP system (see below) can explain the
strong stimulatory effect of VIP in the pig. VIP (and the β-adrenergic receptors) can
stimulate both limbs of the signaling pathways by a Gs/Gi switching mechanism to increase
both cellular cAMP and Ca2+ (251).
Other neurotransmitters acting on the exocrine pancreas are Neuropeptide Y (NPY), galanin
(93, 390) and histidine isoluecine (161) that have modulatory effect, with NPY mainly
controlling blood flow to induce vasoconstriction and inhibit pancreatic secretion. Substance
P and the calcitonin gene-related peptide (CGRP) are co-localized in the same neuron and
act as inhibitory neurotransmitters (56).
Regulation of salivary glands function is not understood to the same extent as pancreatic
function. Salivary gland function is also controlled by multiple inputs, endocrine, paracrine
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and neuronal (274, 342, 377). The main neuronal regulation is by parasympathetic and
sympathetic nerve endings. The parasympathetic neurons release acetylcholine to activate
the M1 and M3 receptors in both acinar and duct cells (38, 71, 114, 451) to increase [Ca2+]i
and mainly stimulate fluid secretion. The sympathetic nervous system activates β-adrenergic
receptors in acinar and duct cells to increase cAMP (23, 48, 75). β-adrenergic stimulation is
the main pathway for stimulated enzyme secretion in acinar cell (48). In the duct, β-
adrenergic stimulation controls fluid and electrolyte transport (66), including HCO3−
secretion (389, 472).
Salivary glands acinar and duct cells express a battery of ionotropic and metabotropic P2
receptors (P2Rs) both in the luminal and basal membranes (415, 465). The P2Y receptors
appear most important in gland development (22, 416) and perhaps repair (350). The P2X
receptors (287, 307, 465) may have a role in fluid and electrolyte secretion. A recent
convincing study showed a prominent stimulation of salivary glands secretion by the P2X7
receptors (287), which are expressed in both acinar and duct cells (242, 354) and act by
increasing [Ca2+]i (242, 287, 307). How the function of all inputs is orchestrated to produce
the final saliva (and for that matter, the pancreatic juice) is not known at present.
D. Signaling Pathway in Secretory Glands
Acinar and duct cell functions in both the pancreatic and salivary glands is regulated by
receptors that change the free cytoplasmic Ca2+ concentration ([Ca2+]i) (208, 337). Changes
in [Ca2+]i are also critically involved in pancreatic (205, 330) and salivary glands (205)
pathology. Ca2+ signaling entails receptor-mediated activation of the G proteins Gq to
generate Gαq·GTP or Gi to release Gβγ, which activate phospholipase C β (PLCβ). PLCβ
hydrolyses PIP2 to generate IP3 and diacylglycerol (32). IP3 activates the ER-located Ca2+
release channels IP3 receptors (IP3Rs) (276), with IP3R2 and IP3R3 being the major
isoforms in secretory cells (110). Ca2+ release is followed by activation of plasma
membrane Ca2+ influx channels, the so called store-operated channels (SOCs). The two
SOCs are the Orai (104, 427, 468) and TRPC channels (167, 447, 463). The TRPC and Orai
channels are activated by the ER Ca2+ sensor STIM1 (246, 366). In response to Ca2+ stores
depletion, STIM1 clusters with TRPC (6, 323, 467) and the Orai channels (83, 246, 249,
419) to activate them. The increase in [Ca2+]i activates the Ca2+ extrusion mechanisms, the
sarco/endoplasmic Ca2+ ATPase (SERCA) pumps and the plasma membrane Ca2+ ATPase
(PMCA) pumps, to move Ca2+ from the cytosol and restore [Ca2+]i towards the basal level.
The Ca2+ signal in epithelial cells is highly polarized, initiating at the apical pole and
propagating to the basal pole (196, 414). Polarization of the Ca2+ signal is achieved by
polarized arrangement of all Ca2+ signaling proteins and their assembly into complexes in
close proximity of the tight junction. Polarized expression has been demonstrated for all
three IP3Rs (240, 293, 446), the SERCA and PMCA pumps (239, 474), GPCRs (357, 392),
TRPC channels (203), Orai channels and STIM1 (163, 253). Such an arrangement launches
the Ca2+ signal at the cellular domain that initiates the polarized cellular function of the
cells, being exocytosis of secretory granules or stimulated fluid and electrolyte secretion.
The Ca2+ signal evoked by physiological agonist concentrations is in the form of Ca2+
oscillations, where the Ca2+ signal is periodically repeated. The frequency and amplitude of
the oscillation is determined by the intensity of receptor stimulation (31, 208). The Ca2+
oscillations always start at the apical pole and propagate to the basal pole (196, 414) in the
form of Ca2+ waves (197). In pancreatic acinar cells the oscillations can remain confined to
the apical pole (333, 337, 414). Interestingly, the spatial and temporal aspects of the Ca2+
oscillations vary among pancreatic and parotid acinar cells (120), likely reflecting adaptation
of the Ca2+ signal to the specialized function of the two cell types. The Ca2+ signaling
pathway mediates exocytotic enzyme secretion by pancreatic acini (438, 439), fluid
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secretion by pancreatic and salivary glands acini (274, 331), and modulate ductal fluid and
electrolyte secretion (see below).
The second signaling pathway is the cAMP/PKA pathway that is activated by receptors
coupled to Gs, as is the case in the ducts. The main stimulator of pancreatic ductal secretion
is secretin and of salivary ducts function is norepinephrine acting on the β-adrenergic
receptors. Secretin receptors belong to the class B G-protein-coupled receptor (GPCR) and
β-adrenergic receptors are class A GPCR. Stimulation of the two receptor types in duct cells
evokes an increase in cAMP and activation of PKA (66, 75, 88, 100, 417). Stimulation of
the VIP receptors in duct cells (VPAC1), also activates the cAMP/PKA pathway (100, 417).
The main transporters activated by cAMP to evoke fluid and HCO3− secretion are the
luminal CFTR and the basolateral Na+-HCO3− cotransporter (237, 369) NBCe1-B (458). In
the pancreatic duct, anti-secretin antibodies block about 80% of postprandial HCO3− output
(57), highlighting the central role of secretin in stimulating HCO3− secretion.
In recent years, a more complicated picture of the regulation of ductal fluid and electrolyte
secretion has emerged with the realization that pancreatic and salivary gland cells express a
multitude of receptor types. In the pancreatic duct, these include multiple P2 receptors (252,
297) and the protease-activated receptor 2 (PAR2) (9, 290, 292, 299), which in addition to
stimulating secretion (287), may mediate critical steps in apoptosis (P2X7 receptors) and the
inflammatory response (PAR2) associated with pancreatitis. The P2X7 receptors may have
different roles in acinar and duct cells since the receptors show cell specific behavior (242),
and pore expansion (241). Functional studies suggest expression of P2Y2R and P2X7R at
the luminal membrane and perhaps P2Y1R, P2Y2R and P2X4R at the basolateral membrane
of the duct (252). Both the P2Y and P2X receptors signal through changes in [Ca2+]i (302).
Subsequently, it was reported that the basolateral P2Rs inhibit HCO3− and fluid secretion in
guinea pig duct (176). The P2Y11R that signal through changes in cAMP stimulates a
luminal Cl− channel, most likely CFTR (297). The basolateral PAR2 that signals via
changes in [Ca2+]i activates the luminal Ca2+-activated Cl− and K+ channels (299) and
stimulates ductal HCO3− secretion (9). Again, to what extent these various receptors
contribute to fluid and HCO3− secretion in vivo is not clear at present. However, the PAR2
and P2X7 receptors may become particularly active in pathological states when significant
trypsin and ATP are released to protect the cells.
E. Synergism
The cAMP and Ca2+ signal pathways show prominent synergism in many physiological
functions. A particularly well defined synergism is fluid and HCO3− secretion by the
pancreatic duct and will be used here to illustrate the phenomenon. Although secretin is the
primary stimulator of pancreatic fluid and HCO3− secretion, exogenous application of
secretin that elevates plasma concentration to the level observed in the postprandial state
evokes only modest HCO3− and fluid output (87, 136). This suggests that other factors, such
as CCK and vagal stimulation, synergize with secretin to stimulate ductal fluid and HCO3−
secretion. A decrease in secretin-evoked HCO3− secretion by the cholinergic muscarinic
receptors antagonist atropine and by vagal blockade indicates that a vagal cholinergic input
is important for postprandial HCO3− secretion (134, 216). In addition, exogenous in vivo
application of CCK potentiates the secretin-stimulated fluid and HCO3− secretion (460).
Stimulation of both the M1 and M3 and CCK receptors (CCKA) in pancreatic duct cells
evoke an increase in [Ca2+]i and potentiate the effect of cAMP agonists such as secretin and
VIP (237).
The mechanism of synergism between cAMP and Ca2+ signals in pancreatic duct cells is not
yet fully understood. Activation of Ca2+-activated K+ channels in the basolateral membrane,
which facilitates anion secretion through CFTR in the apical membrane, seems to be one
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plausible mechanism that has been demonstrated in several epithelia (60, 226). A second
mechanism is Ca2+-dependent activation of CFTR-dependent Cl−/HCO3− exchange shown
in CAPAN-1 human pancreatic duct cells (291). This mechanism may involve activation of
CFTR by IRBIT. The regulatory role of IRBIT is discussed in detail below and in a recent
review (457). For the current discussion, it is necessary to know that IRBIT binds to the
IP3Rs to inhibit their function, and it is released from the IP3Rs by IP3 (11). IRBIT also
activates both the Na+-HCO3− cotransporter NBCe1-B (394, 458) and CFTR (458).
Stimulation of a Ca2+ mobilizing receptors that results in an increase in IP3 may result in
dissociation of IRBIT from the IP3Rs and its binding to NBCe1-B and/or CFTR to activate
them and increase the cAMP-activated fluid and HCO3− secretion. A reciprocal form of
synergism is an augmentation of the [Ca2+]i signal by cAMP. In parotid acinar cells, cAMP/
PKA phosphorylates the IP3R2 to increase channel open probability and hence augments the
Ca2+ signal (38). Finally, Ca2+ can positively control the cAMP/PKA system. Several
adenylyl cyclases (ACs), such as AC1 and AC8, are activated by elevated [Ca2+]i (440).
VI. FLUID AND ELECTROLYTE SECRETION BY ACINAR CELLS
A. Overview
Fluid and electrolyte secretion by secretory glands is a two step process, in which acinar
cells secrete isotonic, plasma-like fluid and the duct modifies the electrolyte composition to
generate the final fluid. The volume secreted by acinar cells is different in each gland. For
example, pancreatic acinar cells secrete a small amount of volume and most fluid in the final
pancreatic juice is secreted by the duct (237, 404). On the other hand, in all salivary glands
the serous acinar cells specialize in fluid secretion and secrete most of the fluid in the saliva
(274). Yet, to the extent that they are known, the fundamental mechanism of fluid and
electrolyte secretion by the two acinar cell types is similar, if not identical. The only two
known features that may explain the different rate and volume secreted by pancreatic and
salivary gland cells are the properties of their receptor-evoked Ca2+ signal, which is much
faster in salivary glands acinar cell (120), and perhaps expression of high level of the water
channel aquaporin-5 in salivary gland acinar cell (80). Most mechanistical information on
pancreatic acinar cells fluid and electrolyte secretion comes from relatively early functional
studies and the molecular identity of most transporters is known only to a limited extent (for
review see (331)). Most recent work has been done with salivary gland acinar cells and
relied on gene deletion in mice, which revealed several unexpected features and role of the
transporters (50, 274, 369). Therefore, for the most part, we will discuss fluid and electrolyte
secretion by salivary gland cells and will provide information on pancreatic acinar cells
when available.
B. Acinar Cells Electrolyte Transporters
The Na+/K+ ATPase pump—Fluid and electrolyte secretion is fueled by the cellular Na+
gradient generated by the basolateral Na+/K+ ATPase pump, which hydrolyses ATP to
exchange 3Na+in for 2K+out and one H+in (280) and generate the transcellular Na+ and K+
gradients, and thus also determines the membrane potential (331).
K+ channels—The acinar cell membrane potential is close to the K+ diffusion potential,
which is set by K+ channels. The membrane potential provides the driving force for the exit
of Cl− at the luminal membrane, which is the key step initiating fluid and electrolyte
secretion. Early microelectrodes work recorded K+ conductance in acinar cells that was
activated by Ca2+ (332). With the invention of patch-clamp technique (139), it became clear
that acinar cells express two type of Ca2+-activated K+ channels (331), a Ca2+- and voltage-
activated K+ channel of a large conductance (267) and a time- and voltage-independent K+
channel of intermediate conductance (147, 294). The molecular identity of the channels was
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subsequently determined as the MaxiK channels coded by the Kcnma1 (294, 360) and the
mIK1 channels coded by the Kcnn4 gene (27, 146), respectively. Gene deletion in mice
revealed that both channels are required to sustain acinar cells and salivary glands function.
Thus, deletion of Kcnn4 had no effect on either resting or stimulated acinar cell volume
regulation or glandular fluid and electrolyte secretion, including K+ secretion (27).
Moreover, deletion of the Kcnma1 gene had no effect on salivary glands fluid and
electrolyte secretion (360), although K+ secretion is impaired in salivary glands lacking the
MaxiK channel that is expressed in the luminal membrane of the duct (288). It was
necessary to delete both the Kcnn4 and the Kcnma1 genes in mice to reduce receptor-
stimulated fluid and K+ secretion by acinar cells and thus by salivary glands (362). Acinar
cells appear quite plastic and lack of effect due to deletion of one of the K+ channels may
result from adaptation of the acinar cells. Example for acinar cells plasticity and adaptability
are also seen in deletion of the Na+/H+ exchange NHE1, which resulted in extensive
adaptation to increased Cl−/HCO3− exchange activity, probably by enhanced expression of
carbonic anhydrase II, and increased expression of of NKCC1 (121). Another example is the
partial deletion of the ER Ca2+ pump SERCA2 that resulted in adaptation of the Ca2+
signaling and granule exocytotic machineries (474).
NKCC1—A key transporter for acinar cells fluid and electrolyte secretion is the Na+/K+/
2Cl− co-transporter NKCC1. NKCC1 is ubiquitous and is activated by cell shrinkage to
mediate regulatory volume increase to restore cell volume after cell shrinkage (78, 225).
NKCC1 is expressed in the basolateral membrane of acinar cells (99) and is inhibited by the
diuretics furosemide and bumetanide (137). Manipulation of external ions and the use of
NKCC inhibitors showed that NKCC activity mediates about 70% of the Cl− uptake that is
secreted across the luminal membrane to drive secretory glands fluid secretion (274, 310,
331). NKCC1 together with the Na+/H+ exchanger NHE1 also provide the cytosol with most
of the Na+ necessary to activate the Na+/K+ pump (469, 470). The central role of NKCC1 in
salivary glands fluid and electrolyte secretion was further established by deletion of the
Nkcc1 gene in mice, which resulted in about 70% inhibition of salivary secretion (99).
NHE1 and AE2—The findings that inhibition (310) and deletion of Nkcc1 in mice (99)
inhibited fluid and electrolyte secretion by only 70% indicate that another mechanism can
fuel the secretory process. Partial inhibition of glandular secretion by the Na+/H+ exchanger
inhibitor amiloride and by the Cl−/HCO3− exchanger inhibitor DIDS (227, 266, 310)
suggested that these transporters acting in concert mediate part of the basolateral membrane
Cl− uptake necessary for luminal Cl− secretion. The Na+/H+ exchangers family includes five
members that are expressed in the plasma membrane NHE1-NHE5 (33, 317) and the Cl−/
HCO3− exchangers family includes four members AE1-AE4 (8). Functional (272, 283, 469,
470), immunological (98, 272, 372) and molecular studies (98, 403) identified the acinar
cells basolateral membrane Na+/H+ exchanger isoform as NHE1 and the Cl−/HCO3−
exchanger isoform as AE2. NHE1 and AE2 are ubiquitous, function as the main regulators
of cytoplasmic pH, and are activated by small changes in pHi. NHE1 is activated by acidic
pHi (16) to extrude acid generated by cellular metabolism, while AE2 is activated by
alkaline pHi to extrude excessive cytosolic base (316). By virtue of regulating pHi in resting
and stimulated cells, NHE1 and AE2 are involved in many cellular functions that in
secretory gland cells include mediating part of acinar cells fluid and electrolyte secretion.
Indeed, deletion of NHE1 (28) and AE2 (115) in mice resulted in severe phenotypes.
Although the severe phenotypes precluded using the mice to study the role of NHE1 and
AE2 in exocrine glands functions in vivo, the knockout mice were useful in demonstrating
the functional role of NHE1 and AE2 in isolated secretory cells.
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TMEM16a/Ano1—It has long been recognized that Cl− exits acinar cells by a conductive
pathway (186) that was later demonstrated as the apical Ca2+-activated Cl− channel (CaCC)
(17, 200, 335). The channel has been extensively characterized biophysically to be a
voltage- and Ca2+-activated, time-dependent outwardly rectifying channel (224, 274).
However, the molecular identity of the channel eluded extensive searches until recently.
Several CLC family (274) and bestrophins, in particular Best2 (186), have been suggested as
the molecular identity of CaCC. However, characterization of the various expressed Best
channels did not fully recapitulate the features of the native CaCC (224), and even when
they closely matched these properties, like Best2, deletion in mice showed that Best2 is not
the acinar CaCC (361). Recently, three independent groups have used different approaches
to identify TMEM16a/Anoctamin 1 (ANO1) as the CaCC in several cell types (43, 383,
459). Moreover, TMEM16a/ANO1 is expressed at high levels in the luminal membrane of
salivary glands (383, 459) and pancreatic acinar cells (166) (but not in the duct), knockdown
of TMEM16a/ANO1 by siRNA reduced salivary secretion (459) and knockout in mice
eliminated the CaCC activity in acinar cells (361). It was not possible to use mice with
global deletion of TMEM16a/ANO1 to study its role in secretory glands function since
TMEM16a/ANO1 is required for airway development and most mice die in utero or shortly
after birth (359). Targeted knockout of TMEM16a/ANO1 is necessary to overcome this
problem and to further examine the role of TMEM16a/ANO1 in acinar cells and glandular
function. TMEM16a/ANO1 is expressed in acinar cells, but not the duct. Since the duct also
expresses CaCC (128, 465), it is possible that the duct expresses another isoform of the
TMEM16 family, which consists of 10 members (224). This is discussed further below.
Aquaporins—Transcellular ion secretion results in the obligatory osmotic water flow.
Although water can cross the membrane bilayer, water flow in secretory cells is facilitated
by the water channels aquaporins (AQPs). The AQPs family consists of 13 members, all of
which can function as water channels, but some can transport other molecules like glycerol,
urea, ions and CO2 (425). The AQPs are involved in several cell functions, like cell
adhesion, proliferation, migration and cell survival (425). Although our knowledge of the
complement of AQPs expressed in secretory glands is not complete and sometime
contradictory, the expression and perhaps function of several AQPs is associated with
several diseases of secretory cells, like Sjögren’s syndrome (80) and pancreatitis (210, 315).
When present in the glands, the AQPs show highly restricted and cell specific expression
pattern. For example, AQP1 is expressed in salivary glands endothelial and myoepithelial
cells (16), while it is found in the human pancreatic duct (211), in centroacinar cells and in
both the apical and basolateral domains of intercalated and intralobular ducts (42). However,
deletion of AQP1 in mice has no effect on salivary glands function (272), yet the deletion of
AQP1 in mice results in defective dietary fat processing (254) and pancreatic exocrine
insufficiency in LXRβ −/− mice is associated with a reduction in AQP1 expression (111).
This suggests that perhaps the AQPs have cell specific function in different acinar cells.
Another possibility is adaptation of salivary glands to AQP1 deletion.
The established AQP in acinar cells is AQP5, which is expressed in the luminal membrane
of acinar cells (80). A critical role of AQP5 in exocrine glands fluid secretion was
established by knockout in mice (8, 272) and aberrant trafficking of AQP5 in Sjögren’s
syndrome patients (98, 372, 403). AQP5 knockout in mice reduces salivary glands secretion
by more than 60% (272) and changes in cell volume in response to osmotic perturbations
(317). A key regulatory mechanism of AQP5 activity is trafficking to the plasma membrane
in response to cell stimulation (8). In addition, AQP5 appears to regulate the water
permeability of the paracellular pathway. Deletion of AQP5 disrupted integrity of the tight
junction and reduced the paracellular water permeability (98). Trafficking of AQP5 to the
plasma membrane is impaired in salivary glands of patients with Sjögren’s syndrome (98,
372, 403).
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The salivary glands duct secretes little fluid (66, 274) and does not express AQP5 (258) or
AQP1 (16). However, pointedly, gene transfer of AQP1 to the salivary duct resulted in a
marked increase in salivary glands fluid secretion and increased Na+ in the secreted fluid
(112). Transduced AQP1 is expressed in the luminal membrane of the rat (283) and mini
pigs salivary glands duct (115). This is reminiscent of expression of AQP1 in the pancreatic
duct (210–212), which secretes most of the fluid in the pancreatic juice and does not absorb
the Na+. The simplest interpretation of these observations is that the pancreatic and salivary
gland ducts have different water permeability and luminal membrane water permeability of
the ducts dictates their function in secretory glands. In the salivary glands the duct mainly
regulates electrolyte composition of the secreted fluid, while the pancreatic duct determines
both, electrolyte composition and volume of the secreted fluid. In addition, AQP1 may
reduce the function of ENaC of the salivary gland ducts to allow the net Na+ efflux to fuel
fluid secretion.
C. Model and Regulation
The available information on the localization and function of acinar cells ion transporters
leads to the mechanism of acinar cells fluid and electrolyte secretion illustrated in Fig. 2.
Acinar cells fluid and electrolyte secretion is fueled by the basolateral Na+/K+ ATPase
pump, which set intracellular Na+ at about 20 mM and intracellular K+ at about 140 mM
(64, 221, 336, 338). The basolateral NKCC1 and NHE1 are the main routes of Na+ influx
that feeds the Na+/K+ ATPase pump (469, 470). The basolateral Ca2+-activated K+ channels
set the membrane potential at −50 to −60 mV (186, 331). NKCC1 is the major route of Cl−
influx into acinar cells and together with the Cl−/HCO3− exchanger AE2 sets intracellular
Cl− at about 60 mM, which is 5 fold above electrochemical equilibrium (186, 472). NHE1
and AE2 also set cytoplasmic pH at about 7.2 (272, 282, 283, 295), which is one order of
magnitude below the H+ electrochemical equilibrium, and guard against large fluctuation in
pHi. The main transporters at the luminal membrane are the Ca2+-activate Cl− channel
TMEM16A/Ano1 (224, 361) and the water channel AQP5 (80, 218, 255). The acinar cells
tight junction is permeable to Na+ and is the main route of transcellular Na+ flux (237, 274,
404).
Acinar cells fluid and electrolyte secretion is a Ca2+-initiated and regulated process that can
be augmented by the cAMP/PKA system. The secretory process is initiated by an increase in
[Ca2+]i. As outlined above, the physiological receptor-evoked Ca2+ signal is in the form of
Ca2+ oscillations that initiate at the apical pole and spread to the basal pole in the form of
propagated Ca2+ waves (196, 208, 414). Accordingly, activation of the apical Cl− channel is
the key initial step that initiates acinar cells fluid and electrolyte secretion (224, 361, 459).
Once the Ca2+ waves arrive at the basolateral membrane, they activate the K+ channels (294,
331, 362). Activation of the Cl− and K+ channels leads to Cl− efflux into the luminal space
and K+ efflux to the interstitial space. The Ca2+ increase also activates AQP5 (184, 185).
Hence, KCl efflux is followed by the obligatory water efflux through AQP5 to the luminal
space and cell shrinkage (8, 17, 335). To compensate for the negative charge due to Cl−
secretion, Na+ crosses from the basal to the luminal side mostly through the paracellular
pathway, resulting in NaCl secretion.
Cell shrinkage has two consequences, it facilitates reduction in [Ca2+]i back to baseline and
it activates ion influx across the basolateral membrane. Thus, increase in cell volume
facilitates and a decrease in cell volume decreases the Ca2+ signal (200, 289). Reduction of
[Ca2+]i to basal level inhibits the Cl− and K+ channels to temporally stop fluid and
electrolyte secretion. Most importantly, cell shrinkage activates the volume-sensitive
NKCC1 (137, 159), NHE1 (5) and AE2 (8). The molecular mechanism for activation of
NHE1 and AE2 by cell shrinkage is not well understood, although it involves activation of
several kinases, like PKC and p38 MAPK, and inhibition of PP1 (329). Cell shrinkage leads
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to phosphorylation of NKCC1 by the volume sensitive SPAK kinase (76). The role of these
regulatory mechanisms in secretory glands function, although likely, is yet to be established.
The activated NKCC1 mediates most of the Na+, K+ and Cl− uptake to restore ionic content
and volume of acinar cells. The activated AE2 and NHE1 contribute about 30% of the Na+
and Cl−. Restoration of cell volume and ionic content prepares the cell for the next cycle of
Ca2+-regulated fluid and electrolyte secretion that occurs during every spike of Ca2+
oscillations.
The cycle of the secretory process is highly synchronized and the Ca2+ oscillations are
closely followed by oscillation of intracellular Cl− (and likely K+) that are followed by
oscillations in cell volume (106, 107). Moreover, synchronization extends to entire acini that
function as a syncytium. The acinar syncytium is coupled by gap junctions made of
connexins 26 and 32 (270).
V. DUCTAL FLUID AND HCO3− SECRETION
A. Overview
Exocrine secretion is a two stage process, whereby the acinar cells secret isotonic NaCl-rich
fluid and the ducts modify the ionic composition and in some glands, like the pancreas,
secrete most of the fluid. For long time studies of ductal function lagged behind studies of
acinar cell. Contributing reasons were the fact that acini secret the protein, like digestive
enzymes and mucins, or the bulk of the fluid in the case salivary glands, which were
considered the central specialized function of secretory glands. In addition, the ducts
comprise only between 5% (pancreas and parotid gland) to 20% (submandibular) of the
gland cell volume, which limited access to the ducts. Advances in molecular, cellular and
physiological techniques over the past 25 years changed this and revealed the molecular
identity, function and regulation of ductal ion transporters at the basolateral and luminal
membranes (274, 471). Major discoveries are the identification of anion channels in the
luminal membrane, such as CFTR and CaCC; identification of the basolateral Na+-HCO3−
cotransporter (234, 471), which was shown to be critical for pancreatic HCO3− secretion
(180) and cloned as pNBC1 (1) and later re-named NBCe1-B (35). A breakthrough was
made with the discovery of the Cl−/HCO3− exchangers SLC26 transporters (160) and the
recognition of their essential role in epithelial HCO3− secretion (91, 215). Yet another
significant finding was the discovery of HCO3− absorbing mechanisms like NHE3 (234,
250) and NBC3 (NBCn1-A) (250, 327) at the luminal membrane of the ducts, which
suggested the ducts absorb and scavenge HCO3− in the resting state. The major ion
transporters expressed in the luminal and basolateral membranes of the duct are summarized
in Tables 1 and 2, respectively, and illustrated in Fig. 3. Expression and membrane
localization of these transporters have been demonstrated in the pancreatic and salivary
ducts, including the exception of ENaC, which is expressed only in the luminal membrane
of salivary glands duct (65, 66). Accordingly, salivary gland ducts absorb the Na+ from the
saliva, whereas the pancreatic duct does not absorb but secrete Na+ into the pancreatic juice.
B. Duct Cells Electrolyte Transporters
Na+/K+ ATPase—The Na+/K+ ATPase pump is abundantly expressed in the basolateral
membrane of the ducts (256, 369, 399, 410). The primary Na+/K+ ATPase pump in
conjunction with the basolateral K+ channels uses and converts the chemical energy in ATP
to osmotic energy in the form of the Na+ and K+ gradients and a negative membrane
potential, which fuel fluid and electrolyte secretion by the duct. The Na+ gradient is used for
HCO3− accumulation in the cytosol and the membrane potential facilitates HCO3− fluxes by
electrogenic transporters at the basolateral and luminal membranes.
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K+ channels—Although the activity of several K+ channel is found in duct cells, the
molecular identity of the major K+ channel is not fully established. In the pancreatic duct
MaxiK channels are the likely candidates maintaining a negative membrane potential during
HCO3− secretion (124). These channels are activated by Ca2+, have a large conductance
(125–250 pS), and are encoded by the Kcnma1 gene (30). In earlier reports MaxiK+
channels were thought to be localized at the basolateral membrane of pancreatic duct cells
(298). However, a recent study revealed that MaxiK channels are expressed at the luminal
membrane in guinea pig pancreatic duct cells (423). Such a localization may account for the
increased Ca2+ sensitivity of the MaxiK channels by the cAMP/PKA pathway, and
contributes to the secretin-induced ductal secretion (124). In addition, activation of luminal
MaxiK channels can account for part of the potentiation of ductal fluid and HCO3− secretion
by Ca2+ mobilizing receptors.
Luminal localization of the MaxiK channels was also observed in salivary gland ducts (288).
Such localization indicates that another K+ channels must be expressed at the basolateral
membrane of the duct. Indeed, MaxiK channels do not seem to contribute to duct cells
resting membrane potential, possibly because they have very low open probability at the
unstimulated state. A potential basolateral K+ channel is Ba2+-sensitive channel of 82 pS
conductance, which is the main channel responsible for the resting K+ permeability (305). In
this respect, as outlined above, salivary glands express two K+ channels, the MaxiK (294,
360) and the mIK1 channels (27, 146). The salivary glands absorb the Na+ and secrete K+
into the salivary fluid. Deletion of the Kcnma1 gene coding for MaxiK had no effect on
salivary glands fluid secretion (360), but impaired K+ secretion (288), establishing the role
of MaxiK as the channel that controls K+ efflux and determines the potential of the luminal
membrane. Since deletion of the Kcnn4 and the Kcnma1 genes in mice reduced receptor-
stimulated fluid and K+ secretion by salivary glands (362), it is likely that mlK1 is the K+
channel at the basolateral membrane of the duct. The use of the available mice with single
and combined deletion of the Kcnn4 and Kcnma1 genes should allow addressing this
problem directly in the salivary glands and pancreatic ducts.
Na+-HCO3− cotransporters (NBCs)—HCO3− secretion requires HCO3− entry at the
basolateral membrane with transport characteristics adequate to maintain HCO3−
accumulation in the cytoplasm. A search for such mechanisms identified a Na+/H+ exchange
activity with properties of NHE1 and a Na+-HCO3− co-transport (NBC) activity with the
properties of what became known as NBCe1-B in the basolateral membrane of the rat
pancreatic duct (470). After the initial discovery of NBC activity in the rat pancreatic duct,
similar activity was demonstrated in all other species examined, including the guinea pig
duct (178, 347). The basolateral NBC isoform was cloned from the pancreas and named
pNBC1 (1). After identification of all members of the superfamily of Na+-driven HCO3−
transporters it was re-named NBCe1-B (35). NBCe1-B is expressed at the basolateral
membrane of most, if not all, epithelia, including salivary gland acinar and duct cells (250).
While NHE1 functions as electroneutral exchanger, NBCe1-B is an electrogenic transporter
with most likely 1Na+-2HCO3− stoichiometry, although NBCe1-B stoichiometry appears to
depend on the cell type in which it is expressed (131), and can be altered by PKA-dependent
phosphorylation at Ser1026 (130). The electrogenic NBCe1-B uses the Na+ gradient more
efficiently than NHE1 to accumulate cytosolic HCO3− and indeed NBCe1-B mediates the
bulk of basolateral HCO3− entry during ductal fluid and HCO3− secretion (180, 183).
Significantly, NBCe1-B behaves as a 1Na+-2HCO3− cotransporter when expressed in a
pancreatic ductal cell line (131). Although the stoichiometry of the transport was not directly
measured in native pancreatic ducts, it is considered to be 1Na+-2HCO3− in the stimulated
duct since it mediates HCO3− influx across the basolateral membrane (404), which at a
membrane potential of −60 mV is possible only with a 1Na+-2HCO3− stoichiometry. The
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activity of NBCe1-B is regulated by the protein named IRBIT (394, 457), the mechanism
and significance of which is discussed in detail bellow.
The duct also expresses an electroneutral NBC in the luminal membrane (327) that was
cloned as NBC3 (343) and later re-named NBCn1-A. The finding of Na+ and HCO3−
absorbing mechanisms at the luminal membrane of the duct was unexpected. Similar to the
case of NHE3 (see below) (3), NBCn1-A (327) is regulated by CFTR in a cAMP-PKA-
dependent manner. Stimulation of CFTR with PKA leads to inhibition of NHE3 and
NBCn1-A (3, 327). NHE3 (150) and perhaps NBCn1-A (35) are also activated by IRBIT
(see below). Based on their regulation by IRBIT and stimulated CFTR, we proposed that
NHE3 and NBCn1-A are part of a HCO3−-regulating complex in the duct, which serves as a
HCO3− salvage mechanism at the resting state to maintain acidified pancreatic juice (118,
263) and saliva (250).
Cystic fibrosis transmembrane conductance regulator (CFTR)—CFTR was
discovered as the protein mutated in cystic fibrosis (199, 356, 364). Since its discovery,
CFTR became one of the most extensively studied protein and serves as a model to
understand the function of proteins of similar structure and function. CFTR (ABCC7)
belongs to the ATP-binding cassette (ABC) transporters superfamily. Most ABC
transporters function as membrane pumps for organic molecules, which transport their
substrates against the electrochemical gradient using energy generated from ATP hydrolysis
(74). Unlike other ABC transporters, CFTR has anion channel activity that conducts the
substrate molecule down the electrochemical gradient. In expression cloning, CFTR
functions as a small conductance (5–10 pS) Cl− channel with a linear current-voltage (I-V)
relationship that is activated by the cAMP/PKA pathway (411). Channels with similar
properties have been identified in the pancreatic and salivary gland duct cells of many
species, including humans. The presence of CFTR in the luminal membrane of the
pancreatic and salivary glands ducts has now been firmly established in many species by
immunohistochemistry (49, 404, 466)
CFTR functions as a Cl− channel with limited permeability to HCO3− at normal intra and
extracellular Cl− (245, 340, 387). Based largely on computer modeling, it has been
suggested that CFTR may function as a HCO3− channel in the pancreatic duct (181, 312,
353, 387, 437). However, several key findings indicate that CFTR-mediated HCO3− flux has
limited and defined role in ductal HCO3− secretion. First, the ducts express luminal, DIDS-
sensitive Cl−/HCO3− exchange activity (235, 424, 471) that is mediated by the luminal
SLC26 transporters (405, 433). Second, CFTR is regulated by extracellular and intracellular
Cl− and at extracellular Cl− of higher than 30 mM it does not transport significant amount of
HCO3− (387, 448). Third, Cl− has to be removed from the luminal space for the duct to
secrete HCO3− through CFTR (181, 325). Forth, deletion of Slc26a6 impairs ductal fluid
and HCO3− secretion (433). Hence, although having a HCO3− selective channel at the apical
membrane of duct cells it is theoretically possible to secrete 200 mM HCO3− at a membrane
potential of −60 mV, the CFTR PHCO3/PCl is between 0.2–0.5 in pancreatic duct cells when
measured with symmetrical Cl− solutions (312, 400). With this permeability ratio, the CFTR
anion channel secretes Cl− much faster than HCO3−, thus CFTR would be unable to secrete
sufficient HCO3− to account for the bulk of the secreted HCO3−. Finally, fluid secretion
requires osmotic HCO3− secretion. Strict exchange of HCO3− for Cl− by CFTR will not
result in osmotic solute secretion.
Nevertheless, CFTR-mediated HCO3− flux can become important at the distal portion of the
ducts to determine the final HCO3− concentration in the secreted fluids. A unique form of
regulation of CFTR activity discovered recently is by the WNK/SPAK pathway. The WNK
kinases were discovered in a search for MAPK homologues and the family consists of four
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members with conserved kinase domain, but diverse N and C termini (reviewed in (164)).
Interest in the WNKs increased greatly with the discovery that mutations in WNK1 and
WNK4 cause hypertension in humans (442). The WNKs act mostly by regulating surface
expression of Na+, K+ and Cl− transporters (194), through regulation of their endocytosis
(165). Subsequent work revealed that many functions of the WNK are mediated by the
downstream oxidative stress-responsive kinase 1 (OSR1) and STE20/SPS1-related proline/
alanine-rich kinase (SPAK) (reviewed in (77)). The WNK/SPAK kinase pathway appears to
have dual function in the ducts. At normal physiological [Cl−]i the WNK kinases reduce
surface expression of CFTR expression (455, 456). In the pancreatic and salivary glands the
WNKs act through SPAK to control the activity of NBCe1-B and CFTR, and knockdown of
the WNKs and SPAK increases pancreatic duct fluid and HCO3− secretion (456). However,
at low cytoplasmic [Cl−]i, as occurs in the distal duct, the WNK/SPAK pathway appears to
have an opposite role. The CFTR HCO3− permeability appears to be dynamically regulated
by intracellular Cl− (325). During pancreatic secretion, [Cl−]i can drop to as low as 5 mM.
This low [Cl−]i in turn activates WNK1 and the downstream OSR1 and SPAK. Activation of
the WNK1/OSR1/SPAK pathway under this [Cl−]i conditions resulted in a dramatic increase
in CFTR HCO3− permeability, making CFTR primarily a HCO3− channel (325). Function of
CFTR as a HCO3− channel at the distal duct can be essential for the secretion of pancreatic
juice containing 140 mM HCO3−. Hence, it appears that under resting conditions and at the
proximal duct the WNK/SPAK pathway reduces NBCe1-B and CFTR activity to stabilize
the resting state and perhaps minimize HCO3− fluxes by CFTR. On the other hand, at the
distal duct an important function WNK/SPAK pathway is to switch CFTR from primarily a
Cl− channel to a HCO3− channel to set the final HCO3− concentration in the secreted fluids.
In addition to Cl− and HCO3− channel activity, CFTR functions as a central regulator of
ductal fluid and electrolyte secretion by virtue of regulating the function of many
transporters at the luminal membrane of the ducts. The central role of CFTR in ductal
function is well exemplified by the aberrant fluid and electrolyte transport and pancreatic
insufficiency seen in CF patients (94). CFTR exists in a macromolecular complex at the
luminal membrane of secretory epithelia, which is assembled with the aid of scaffolding
proteins. The three amino acids at the C-terminal end of CFTR form a PDZ ligand that binds
to PDZ domains containing scaffolds in epithelia (395, 431). In addition, CFTR interacts
with SNARE proteins, AKAPs, kinases and phosphatases (135). In the complexes, CFTR
directly or indirectly regulates the activity of several transporters. Functional interactions
with CFTR were reported for ENaC, outwardly rectifying Cl− channels, Ca2+-activated Cl−
channels, ROMK2 and KvLQT1 K+ channels, the SLC26 transporters, NBCn1-A (NBC3)
and perhaps aquaporins (222, 237). Below we discuss the significance of several of these
interactions for ductal secretion.
Ca2+-activated Cl− channels (CaCCs)—Ca2+-activated chloride channel activity
(CaCCs) is present in the luminal membrane of duct cells (125, 128, 424, 465). The
molecular identity of ductal CaCC is still unknown. The discovery of the TMEM16/
Anoctamin (ANO) family as the CaCC in acinar cells (43, 383, 459) suggest that the ductal
CaCC is likely a member of this family. However, immunostaining shows that TMEM16A/
ANO1 is expressed in the luminal membrane of acinar cells and that the duct does not
express TMEM16A/ANO1 (383, 459). To date, several members of the TMEM16/ANO
family were shown to function as Cl− channels, including TMEM16B/ANO2, TMEM16G/
ANO7, TMEM16J/ANO10 and perhaps TMEM16F/ANO6 (406). Human and rodent
pancreata and the salivary duct express mRNA for several members of TMEM16/ANO
family, including TMEM16B/ANO2, TMEM16F/ANO6 and TMEM16J/ANO10 (MGL and
SM, unpublished observation). Although TMEM16F/ANO6 was reported recently to
function as a phospholipid scrambler (410), it may also function as Cl− channel. It will be
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interesting to determine how the two activities of TMEM16F/ANO6 are related. Whether
the other TMEM16/ANO isoforms also mediate ductal CaCC awaits further studies.
Interest in the ductal CaCC stems from the possibility that it may replace the Cl− channel
function of CFTR in HCO3− secretion. Studies in the human pancreatic duct cell line
PANC1 (476), raise questions as to the feasibility of such a role. Moreover, an increase in
[Ca2+]i alone by stimulation of the cholinergic and CCK receptors does not evoke
significant fluid and HCO3− secretion by the pancreatic duct (460) and cholinergic
simulation of salivary glands result in low HCO3− secretion (45). The PHCO3/PCl of
heterologously expressed TMEM16A is 0.1–0.5 at [Ca2+]i levels normally induced by
receptor stimulation. Interestingly, the PHCO3/PCl permeability of TMEM16A appears to be
regulated by [Ca2+]i (MGL, unpublished observation). The physiological role of this finding
in epithelial HCO3− secretion is not known at present.
Cl−/HCO3− exchangers: AEs and the SLC26 transporters—The pancreatic duct
secretes most of the fluid in the pancreatic juice. The copious fluid secretion must involve
large net transcellular salt transport. Since the pancreatic duct absorbs the Cl− and secretes
fluid containing Na+ and HCO3−, and since Na+ secretion is largely paracellular, it follows
that pancreatic duct HCO3− secretion must be an active process and a 1Cl−/1HCO3−
exchange, whether by coupled or uncoupled transport, cannot lead to net electrolyte
secretion necessary to drive fluid secretion. This puts a thermodynamic constrain as to the
nature of the Cl− absorbing and HCO3− secreting mechanism that must function with a
stoichiometry of HCO3−/Cl− >1. We will argue below that SLC26 transporter Slc26a6 fulfill
this requirement and is critical for pancreatic duct fluid and electrolyte secretion.
Because the absence of CFTR activity in CF results in acidic pancreatic juice, it was
assumed that CFTR directly mediates the tightly coupled Cl− absorption and HCO3−
secretion or function in concert with Cl−/HCO3− exchange to mediate HCO3− secretion by
the duct (49, 169, 404). An early model for pancreatic HCO3− secretion suggested that
electroneutral Cl−/HCO3− exchanger in the apical membrane mediates HCO3− secretion in
conjunction with Cl− channel that cycles the Cl− (237, 400, 401, 404). Subsequently, it was
revealed that CFTR mediates the apical Cl− channel activity and that the activity of the
apical Cl−/HCO3− exchanger is dependent on the expression of CFTR (235, 238).
Furthermore, CFTR mutations associated with pancreatic insufficiency exhibited severe
defect in CFTR-dependent Cl−/HCO3− exchange activity (61). These findings prompted
extensive search to identify the molecular nature and function of the ductal luminal Cl−/
HCO3− exchangers.
The first family of Cl−/HCO3− exchangers to be considered are members of the solute-
linked carrier 4 (SLC4) family (363). The ducts do express the SLC4 transporter AE2
(SLC4A2), but it is located on the basolateral membrane of pancreatic and salivary gland
duct cells (370, 372). AE2 together with NHE1 is essential for regulation of pHi and protects
the cells against an alkali load, but does not appear to play a major role in transcellular
ductal HCO3− transport. A breakthrough in our understanding of luminal Cl−/HCO3−
exchange in epithelia was made with the discovery that the protein previously identified as
down regulated in adenoma (DRA), is a Cl− transporter highly expressed at the luminal
membrane of the colon, and mutation in which lead to the disease congenital Cl− diarrhea
(160, 281). Shortly thereafter it was shown that DRA functions as a Cl−/HCO3− exchanger
(273). With the renaming of the family it is designated as SLC26A3 and is expressed in
several epithelia.
The SLC26 transporters (SLC26Ts) family consists of 11 genes and 10 members (Slc26A10
is pseudo gene) with several members associated with human diseases (for review see (91)).
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The family members have diverse functional properties (314), with SLC26A1 and SLC26A2
functioning as SO42− transporters (262), Slc26a3 and Slc26a6 as electrogenic Cl−/HCO3−
exchangers (214, 449), Slc26a4 as electroneutral Cl−/HCO3−/I− exchanger (389), SLC26A5
functions as an anion regulated, voltage sensing motor protein (376), and SLC26A7 (204)
and SLC26A9 (90) function as bona fide Cl− channels. The function of SLC26A11 is not
known at present. Pancreatic and salivary gland ducts express several members of the
family, including the ubiquitous SLC26A2 and SLC26A11 and Slc26a6 (215, 314), with
salivary glands also expressing Slc26a4 (389). Notably, Slc26a3 functions as an electrogenic
Cl−/HCO3− exchanger with a 2Cl−/1HCO3− stoichiometry (215, 388), while Slc26a6
functions as a 2HCO3−/1Cl− exchanger (209, 388). Slc26a3 and Slc26a6 can also mediate
uncoupled anion currents, with the mode of transport determined by a glutamate residue that
is conserved in all species and in all SLC26Ts (313).
Slc26a6 is the major Cl−/HCO3− exchanger in the salivary and pancreatic duct and is
essential for fluid and HCO3− secretion by the ducts (389, 405, 433). SLC26A6 was
originally identified in a search for novel SLC26Ts (247), and as the oxalate transporter in
the renal proximal tubule (209). Oxalate handling by Slc26a6 mediates oxalate homeostasis
by secreting oxalate into the intestinal lumen, and deletion of Slc26a6 results in urolithiasis
due to increased renal oxalate load (189). Oxalate transport by Slc26a6 is not likely to be
relevant for the pancreatic duct, but may have a role in sialolithiasis (142). An important
feature of the SLC26Ts and CFTR is their mutual regulation. Thus, the STAS domain at the
C terminus of the SLC26Ts interacts with the R domain of CFTR and the interaction is
required for activation of both the SLC26Ts and of CFTR (215). This mode of regulation is
discussed further below.
Na+/H+ exchangers (NHEs)—The NHEs are electroneutral 1Na+/1H+ exchangers.
Phylogenetic analysis indicates that the mammalian alkali cation/proton gene family (the
solute carrier SLC9A or NHE family) is comprised of three general gene clusters: (a) five
plasma membrane-type Na+-selective NHEs (NHE1-NHE5); (b) four organellar cation non-
selective NHEs (NHE6-NHE9); and (c) two distantly related NHE-like genes, termed Na+/
H+ antiporter 1 (NHA1) and NHA2, that have closer homology to the fungal/plant NHA1
and bacterial NhaA (36, 318). The ubiquitous housekeeping NHE1 is essential for pHi
homeostasis (28), and is localized at the basolateral membrane in duct cells (151, 234, 250,
326, 370). In addition, NHE1 can provide a portion of HCO3− influx across the basolateral
membrane during HCO3− secretion. However, NHE1 contribution to HCO3− influx must be
minor, since inhibition of NHE1 by amiloride has minimal effect on secretin-induced fluid
and HCO3− secretion by the pancreatic duct in most species (422, 445).
Interestingly, NHEs are also expressed in the luminal membrane of salivary and pancreatic
ducts (250, 326), which may salvage HCO3− when HCO3− secretion is not required.
Pancreatic juice at resting or low flow rates is acidic and contains high level of CO2,
indicating that an active H+ secreting mechanism is functional at this state (118, 263). NHE2
and NHE3 are localized at the luminal membrane of the large-sized mouse pancreatic and
salivary glands ducts (33, 234, 250, 264, 326). The role of NHE2 is not clear since deletion
of NHE2 in mice had no obvious disease phenotype or altered pH homeostasis and HCO3−
metabolism in several organs expressing NHE2 (384), including the pancreatic (234) and
salivary glands ducts (98, 250). On the other hand, deletion in mice showed that NHE3 is
functional in the luminal membrane of the duct (3). Notably, the luminal NHE3 is associated
with CFTR with the aid of PDZ-containing scaffolding proteins and its activity is regulated
by CFTR in the HCO3− transporting complex (3). In addition, the activity of NHE3 is
regulated by IRBIT (149, 150) (see below).
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V-type H+ pump and H+/K+ ATPase pumps—Early studies in pigs suggested that a
vesicular V-type H+-ATPase pump can function as a HCO3− loading mechanism at the
basolateral membrane of the duct (428). These studies relied mainly on pharmacological
tools that may have not reflected the function of the V-type H+ pump. In this respect, no
effect of H+ pump inhibition was found on fluid and HCO3− secretion in the guinea pig duct
(183). The salivary glands duct was reported to express V-type H+-ATPase pump that shifts
from intracellular organelles to the luminal membrane upon chronic acidosis (374).
However, no functional evidence is available to show participation of the pump in acid
(rather than HCO3−) secretion in salivary ducts.
The topic of ductal H+ pumps was revisited very recently in the rat pancreatic duct to
conclude the function of two H+/K+ ATPase pumps in the duct, the gastric and the non-
gastric type pumps (309). Immunolocalization suggested that both H+/K+ ATPase pumps are
expressed in the lateral and luminal membranes. Based on inhibitor studies, the H+/K+
ATPase pumps were shown to mediate modest H+ clearance from the cytosol of acidified
duct cells (309). However, inhibition of the H+/K+ ATPase pumps with omeprazole and
SCH-28080 strongly inhibited secretin-stimulated ductal fluid secretion (309). Inhibition of
fluid secretion by inhibition of the H+/K+ ATPase pumps appears to be the strongest
evidence for their expression, localization and function in the duct. Functioning of H+/K+
ATPase pumps in the basolateral membrane of the duct can be of particular significance
since pumps can generate very large gradient using the energy in ATP. The gastric H+/K+
ATPase pump generates the steepest ion gradient in mammalian cells of six orders of
magnitude (393). Such a pump in the basolateral membrane can function with NBCe1-B to
markedly enhance HCO3− loading of the duct during stimulation of fluid and HCO3−
secretion. However, this topic needs significantly additional extensive studies in vivo and in
vitro using the available mice with targeted disruption of the H+/K+ ATPase pumps to
establish and better understand the function of these pumps in pancreatic and salivary glands
ductal function.
Aquaporins—Since the paracellular pathway is permeable to water, early models of
epithelial fluid secretion assumed that water follows down its osmotic gradient from the
basolateral to the luminal side via the paracellular pathway. In fact, significant portion of the
water secreted by salivary glands acini does flow through the paracellular pathway (144,
285), including in salivary glands of AQP5-/- mice (198). However, water flow through the
paracellular pathway cannot account for most of the salivary glands water flow. It is now
clear that significant portion of water transport is mediated by the water channels aquaporins
(AQP) and is a regulated process. There are at least 13 AQP genes (AQP0-AQP12) in
mammalian cells (426). Although several members of the AQP family have been reported to
be expressed in the exocrine pancreas (170), AQP1 and AQP5 seem to be the major AQPs in
the pancreatic duct. Immunolocalization indicates expression of AQP1 at both the
basolateral and luminal membranes, and AQP5 at the luminal membrane of pancreatic duct
cells (42, 211, 212). Most notably, the salivary glands duct does not express AQP1, but
when transduced with AQP1 in the rat (24, 79) and mini-pig (112) it secretes large volume
of fluid, highlighting the function and importance of AQP1 in the luminal membrane for
fluid secretion by the duct.
The Epithelial Na+ channel ENaC—Like many other epithelia, the salivary duct
expresses the epithelial Na+ channel ENaC in the luminal membrane (49, 65). ENaC appears
to be the major Na+ absorbing pathway in the salivary glands duct. Deletion of both NHE2
and NHE3 had no effect on ductal Na+ absorption, but inhibition of ENaC by amiloride
inhibited both Na+ and Cl− absorption by the duct in stimulated glands (49). However, these
findings may indicate that the NHEs’ major role is in HCO3− salvage in the resting state,
since they are inhibited in the stimulated state when CFTR is activated (3, 234). ENaC is
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extensively regulated by multiple physiological pathways, as expected from its central
function in salt-sensitive epithelia (228). ENaC activity can be regulated acutely during cell
stimulation. In the salivary glands duct, stimulation of luminal and basolateral P2Y2
receptors inhibits ENaC activity by a pertussis toxin-sensitive and pertussis toxin-
independent pathways (311). The precise mechanism by which P2Y2 receptors regulate
ENaC is yet unknown, although it may involve in part depletion of the lipid PIP2, which
activates ENaC (223, 464).
Of particular physiological significance is the regulation of ENaC by receptors that stimulate
the glucocorticoid-induced kinase 1 (Sgk1), including mineralocorticoids, such as
aldosterone (228). Regulation of ENaC by Sgk1 is biphasic. In the first phase that is
completed in about 30 min, activated Sgk1 increases surface expression of the Na+/K+
ATPase pump in the basolateral membrane and of ENaC in the luminal membrane without
affecting their transcription and translation. In the second phase that requires 6–8 hrs, Sgk1
increases transcription and translation of ENaC (228). ENaC surface expression is regulated
by a well defined endocytotic mechanism that involves the ubiquitin ligase Nedd4-2 (367).
Nedd4-2 regulates ENaC by interaction of Nedd4-2 WW domains with the proline-rich (PY)
motifs (PPPxYxxL) located in the C-termini of the α, β, and γ subunits of ENaC (141).
Nedd4-2 then polyubiquitinates the ENaC subunits to cause their internalization by a
clathrin-coated vesicle endocytosis (430). Nedd4-2 appears to interact mostly with mature
ENaC and the interaction requires their localization in caveolae and interaction of Nedd4-2
and ENaC with caveolin-1 (229). The key regulation of ENaC expression and activity by
Nedd4-2 was recently demonstrated in vivo by showing that deletion of Nedd4-2 in the lung
markedly increased ENaC activity and airway Na+ absorption to reproduce the lung
phenotype observed in cystic fibrosis (206). However, whether this occurs in cystic fibrosis
remains controversial since the lung of the porcine cystic fibrosis model does not show
altered ENaC activity and Na+ absorption (53).
Regulation of ENaC by Sgk1 involves the phosphorylation of Nedd4-2 by Sgk1 on specific
residues. The phosphorylated Nedd4-2 is then sequestered by the scaffolds 14-3-3 to prevent
its interaction with and consequently inhibition of ENaC (228). Phosphorylation of Nedd4-2
by Sgk1 is regulated by the WNK kinases, where the WNKs function as scaffolds to recruit
both Nedd4-2 by Sgk1 to allow Nedd4-2 phosphorylation and ENaC surface insertion (155).
This system is functional in the salivary glands duct, since modulation of Nedd4-2 and Sgk1
activities have the expected effect on ENaC function (85, 351). Furthermore, treatment of
rats with dexamethasone and low Na+ diet resulted in marked upregulation of β and γ ENaC
expression (MGL and SM, unpublished observations). In addition, ENaC and CFTR appear
to affect the activity of each other, but in a mechanism that appears to be different from that
in the lung (29, 49). In the lung, CFTR is proposed to inhibit ENaC channel function and
deletion of CFTR may increase ENaC activity, which can be clearly demonstrated in an in
vitro models (29). However, in salivary glands deletion of CFTR inhibited Na+ absorption
by ENaC and inhibition of ENaC function markedly inhibited CFTR-dependent Cl−
absorption (49). Deletion of CFTR resulted in almost elimination of α ENaC expression
(49). This likely explains the marked reduction in ENaC activity in CF patients sweat duct
(352). It will be of particular interest to determine expression of CFTR and ENaC in
different tissues in the various CF models.
C. Diversity of Other Channels and Transporters
Several transporters show organ and species specific expression and in these cases limit the
conclusions to the specific organ and species. The pancreatic duct is unique among
absorbing and secretory epithelia, including the salivary glands duct, in that it does not
express ENaC, and thus it does not absorb Na+. In fact, the pancreatic duct secretes Na+,
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which passes paracellularly (14, 404). Paracellular Na+ secretion is essential for fluid
secretion by the duct not only to maintain electroneutrality, but also as an osmolyte.
NKCC1 (SLC12A2) shows highly species specific expression. It is expressed at the
basolateral membrane in a variety of Cl− secreting epithelia and it is expressed in the rat and
mouse pancreatic duct (103), but not in the pig and guinea pig pancreatic duct (103, 133) or
the salivary glands duct (99, 465). NKCC1 maintains [Cl−]i higher than its equilibrium
concentration, and hence facilitates Cl− secretion when apical Cl− channels are opened. This
may account for the relatively high Cl− concentration of the secretin-stimulated rat and
mouse pancreatic juice and perhaps the lack of pancreatic phenotype in the cystic fibrosis
mice models CFTR-/- and ΔF/ΔF. The lack of NKCC activity in pig and guinea pig
pancreas (103, 133) (and likely human pancreas), may explain the severe pancreatic
phenotype in human with CF (441) and pigs with deleted CFTR (53). As discussed below, a
low ductal [Cl−]i is critical for producing pancreatic juice with the final high concentration
of HCO3−. The lack of NKCC1 in the pig and human pancreas may serve this purpose to
allow the high HCO3− concentration in their pancreatic juice.
VI. REGULATORY PROTEINS OF EPITHELIAL HCO3− SECRETION
A. PDZ-Based Adaptors
HCO3− transport by the duct is mediated by multiple transporters that are assembled into
complexes by adaptor proteins containing PDZ domains. PDZ domains were identified as a
conserved domain in three proteins, Post-Synaptic-Density-95, Disc-large, and Zonula
Occludens-1. The PDZ domain is a protein-protein interaction module consisting of 80–90
amino acids which typically binds to target proteins harboring specific C-terminal sequences
called PDZ-binding motifs or ligands (201). PDZ domains have two major functions. 1)
They anchor protein, including integral membrane proteins such as receptors, transporters,
channels and adhesion proteins, through their PDZ-binding motifs and 2) they bind to the
PDZ domains of other PDZ proteins, thus forming scaffolding networks mediated by homo-
and heteromultimers (117). Initially, PDZ-based adaptors were known to play an important
role in the efficiency and fidelity of synaptic transmission in neurons (201). Subsequent
studies revealed that epithelial cells express a battery of adaptors with PDZ domains and
these proteins perform critical roles in the transepithelial fluid and electrolyte transport. The
role of PDZ-based adaptors in ductal secretion is illustrated in Fig. 4.
The first family of PDZ proteins shown to be involved in epithelial transport is the Na+/H+
exchanger regulatory factor (NHERF) family. NHERF1 (EBP50), NHERF2 (E3KARP), and
NHERF3 (CAP70, PDZK1) facilitate the PKA-dependent phosphorylation and membrane
trafficking of CFTR and NHE3 in epithelial cells, including duct cells (89, 435). By virtue
of expressing multiple PDZ domains, these adaptors assemble a large protein complex in the
apical membrane in which CFTR functions as a central regulator of secretory epithelia. The
requirement of CFTR and the SLC26 transporters for fluid and HCO3− secretion by duct
cells raised the question of how CFTR and the SLC26 transporters communicate to regulate
HCO3− secretion. The answer was provided by the discovery of the interaction and
reciprocal regulation of CFTR with the ductal HCO3− secretory machinery. Particularly, the
interaction and mutual regulation of CFTR with the HCO3−-secreting SLC26 transporters
(SLC26Ts) is mediated by the phosphorylated CFTR R domain and the SLC26Ts STAS
domain and is enhanced by the interaction of CFTR and the SLC26Ts with PDZ scaffolding
proteins (213). In addition, CFTR is involved in the regulation of the luminal HCO3−
absorbing transporters NHE3 and NBCn1-A by forming a protein complex via adaptors with
multiple PDZ domains such as NHERF1 and NHERF2 (3, 250, 327). As a result, the cAMP/
PKA pathway activates CFTR and apical Cl−/HCO3− exchange and inhibits NHE3 and
NBCn1-A (89, 435). Assembling a complex with a large number of transporters with the aid
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of PDZ adaptors greatly enhances signaling efficiency and fidelity of the cAMP/PKA
pathway in confined regions of the luminal membrane. Upon stimulation with cAMP, CFTR
activates the HCO3−-secreting and at the same time inhibits the HCO3−-absorbing
transporters to optimize fluid and HCO3− secretion.
In addition to the NHERFs, duct cells express several other scaffolds with PDZ domains,
such as Shank2, S-SCAM, SAP97, and PSD-95 (116, 202). The Shank family of proteins
was discovered as molecular scaffolds in neuronal cells, where they serve as coordinators of
membrane and cytoplasmic protein complexes in the postsynaptic density (PSD) (244, 391).
The Shanks contain multiple protein-protein interacting domains, including ankyrin repeats,
an SH3, a PDZ, a long proline-rich region and a sterile α motif (SAM) (391). Currently,
there are three known members of the Shank family, Shank1-3. Among them, Shank2
localizes at the apical pole of pancreatic duct cells and modulates the activity of CFTR and
NHE3 (140, 202). Expression of Shank2 upregulates the membrane expression of CFTR and
NHE3, and this appears to be related to activation of Rho small GTPases by recruiting βPix
(PAK-interacting exchange factor), a guanine nucleotide exchange factors (GEF) for the
Rho small GTPases (232). By contrast with NHERF proteins that deliver cAMP/PKA
signals to CFTR and NHE3, Shank2 mediates an inhibitory effect on the cAMP/PKA
pathway. A detailed examination of binding partners of Shank2 revealed that Shank2
associates with phosphodiesterase 4D (PDE4D) that hydrolyzes cAMP, hence lowering local
cAMP concentration in the apical microdomains (231). These findings revealed a unique
form of regulation, whereby opposite signals can be delivered to the same PDZ-binding
motif of a given protein by different adaptors, serving as a homeostatic system to regulate
intensity of the stimulated state (231).
Notably, most ductal GPCRs have PDZ ligands at their C-termini (see fig. 4). This recruits
the GPCRs to the transporting complex resulting in polarized expression of GPCRs (239,
240, 357, 392) and delivery of the second messengers to the ion transporting microdomain.
This should allow confined and better controlled delivery of the stimulus. A good example
for such an arrangement is of the VIP receptor VPAC1, which binds through its PDZ ligand
to the synaptic scaffolding molecule (S-SCAM), also known as membrane-associated
guanylate kinase inverted-2 (MAGI-2) (116). S-SCAM/MAGI-2 associates with E-cadherin,
a key protein at the adherens junction, in a β-catenin dependent manner (408) and recruits
VPAC1 to the junctional area at the apical pole of epithelial cells. Thus, S-SCAM/MAGI-2
confines VPAC1 to the junctional domain to restrict VIP-induced cAMP signaling to
activate CFTR at a microdomain in the vicinity of the apical pole. This, in turn, enables
efficient electrolyte and fluid secretion in response to VIP with minimal effects on the cell
interior (116). Fig. 4 lists the many ductal HCO3− transporters and GPCRs that have a
typical PDZ ligand at their C-termini.
B. With-no-lysine (WNK) and Sterile 20 (STE20)-like Kinases
Recently, two families of protein kinases, the WNK kinases and the sterile 20 (STE20)-like
kinases, have emerged as osmotic sensors that modulate the activity of diverse ion
transporters (13, 194, 355). The family of the WNKs was discovered by search for a MAPK
homologues (450) and were found to lack the conserved lysine in the kinase catalytic site.
Crystal structure of the kinase domain showed the lysine is contributed by the β2, rather
than the β3 strands (277). The family consists of four large members with only the kinase
domain highly conserved (164). The WNKs gained prominence with the seminal discovery
that mutations in WNK1 and WNK4 lead to hypertension (442). Subsequent extensive
studies of their function showed that WNK1, WNK3 and WNK4 function mainly to reduce
the surface expression of various Na+, K+ and Cl− transporters, including NKCC1, NKCC2,
NCCT, KCCT, ENaC, ROMK and Cl− channels (164, 165, 194, 355), including CFTR (455,
456) and Slc26a6 (193). The WNKs reduce transporters surface expression by promoting
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their endocytosis (148, 165). In most cases examined, the WNKs do not act directly on the
ion transporters, but act on the downstream kinases, the STE20-like kinase SPAK and the
oxidative stress-responsive kinase 1 kinase OSR1. The WNKs can phosphorylate the SPAK/
OSR1 on T233, which activates SPAK/OSR1 and the activated SPAK/OSR1 phosphorylates
the ion transporters to reduce their surface expression (355). In several cases, the kinase
function of the WNKs was not required for regulation of the ion transporters. In these cases
the WNKs act as scaffolding proteins that bind SPAK/OSR1 to recruit it to the transporters
(13, 148, 155, 164, 456). The scaffolding function of the WNKs resides in their first 119
residues (148, 155, 456). The human mutations in WNK1 and WNK4 result in inhibition of
NKCC2, NCCT and ENaC endocytosis to enhance their surface expression in the kidney,
leading to excessive Na+ absorption and hypertension (165, 194, 355).
WNK1 (325, 442, 456), WNK3 (456), WNK4 (442, 456), SPAK and OSR1 (325, 456) are
abundantly expressed in ductal systems, including the pancreatic (325, 456) and salivary
glands ducts (456). Recent studies from our laboratories revealed that the WNK/SPAK
pathway appears to have dual roles in regulating ductal function at the resting and stimulated
ducts. The WNK/SPAK pathway stabilizes the ductal resting state by prominently reducing
the surface expression of all ductal transporters involved in fluid and HCO3− secretion
(456). Thus, the WNKs act as scaffolds in which only a short segment of the WNKs N
terminal domain that lacks kinase function (155, 456) binds and recruit SPAK to the Na+-
HCO3− co-transporter NBCe1-B (pNBC1) and CFTR to reduce their surface expression and
dramatically reduce their activity at the plasma membrane (456). The WNK/SPAK pathway
also reduces the surface expression (325) and activity (193, 325) of the ductal SLC26
transporters. Moreover, knockdown of the WNKs increases the activity of ductal NBCe1-B,
CFTR and stimulated fluid secretion (456). The prominent inhibition of ductal fluid and
electrolyte secretion by the WNK/SPAK pathway suggests that the WNK/SPAK pathway
stabilize the resting state of the duct.
Regulation of the WNK/SPAK/OSR1 kinase activity is poorly understood and for the most
part it is not known how these kinases are activated by stimulation of cell surface receptors
or during changes of cellular activity. One well established exception is regulation of the
WNK/SPAK/OSR1 kinases by osmotic stress. The WNK kinases, including WNK1, are
activated by osmotic stress such as that caused by a decrease in [Cl−]i. The activated WNK1
then phosphorylates and activates the SPAK and OSR1 kinases (355). Indeed, when the
human pancreatic duct cell line PANC1 and guinea pig ducts are exposed to low external
and intracellular Cl−, the WNK1-SPAK/OSR1 pathway affects the function of two apical
HCO3− transporters (325). First, the WNK1-SPAK/OSR1 increases CFTR Cl−/HCO3−
selectivity to increase the CFTR HCO3− permeability. Second, the WNK1-SPAK/OSR1
inhibits the apical Cl−/HCO3− exchange by the SLC26 transporters. When occurring in the
terminal portion of the stimulated pancreatic duct, the two functions will result in pancreatic
juice containing HCO3− at a concentration greater than 140 mM.
C. IRBIT (inositol-1,4,5-triphosphate (IP3) receptors binding protein released with IP3)
IRBIT was discovered several times in different contexts (83, 457), most recently in a search
for proteins that interact with the IP3-binding domain of the IP3 receptors (IP3Rs) (11).
IRBIT competes with IP3 for interaction with N terminal domain of IP3Rs to play important
role in the function of the IP3Rs and Ca2+ signaling (10, 82). Subsequent search for proteins
that interact with IRBIT discovered that IRBIT interacts with and regulates the activity of
the Na+-HCO3− co-transporter NBCe1-B (394). There are two highly homologous IRBIT
isoforms, a short and a long IRBIT, with the long IRBIT having an N terminal extension
(12). The domains common to short and long IRBITs are an N terminus PP1 anchoring site
that is followed by a PEST domain (81, 83), a coiled-coil domain and a PDZ ligand at the
end of the C terminus (83). The PEST domain has multiple phosphorylation sites (10), with
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phosphorylation of key residues, including S68, S72 and S74, that are required for all known
IRBIT functions, including regulation of IP3Rs function (10, 82) and activation of ion
transporters (394, 458). Long IRBIT has an N terminal extension rich in prolines and
alanines, which differentiates the roles of short and long IRBIT functions (12).
In the duct IRBIT accumulates at the apical pole (458), a site of expression of high level of
IP3Rs, but IP3Rs and thus IRBIT are also present in the basal pole (240). At the apical pole
IRBIT regulates CFTR (456, 458), and possibly NHE3 (150) and NBCn1-A (35), while at
the basal pole IRBIT regulates NBCe1-B (394, 456, 458). The NBCs are members of the
superfamily of Na+-coupled HCO3− transporters (NCBT), which includes the electrogenic
NBCe1-A~C and the electroneutral NBCn1-A~H (35). The domain structure and function of
the NCBTs are discussed in several recent reviews (35, 344). Notably, the first 45–62
residues of N terminus of several NBC, including NBCe1-B and NBCn1-A, forms an
inhibitory domain and its deletion results in marked activation of the relevant NCBTs (268).
Importantly, IRBIT interacts with the N terminal domain of NBCe1-B to markedly activate
NBCe1-B (394). Activation of NBCe1-B by IRBIT is mediated by the PEST domain (394,
458) and required the PDZ ligands to assemble the IRBIT-NBCe1-B complex (458). These
findings suggest that IRBIT induce a conformational change in NBCe1-B to dissociate its N
terminal inhibitory domain from the transmembrane domain mediating the ion transport.
Most notably, IRBIT activates the native NBCe1-B in pancreatic (456, 458) and salivary
gland ducts (456).
Activation of NBCe1-B by IRBIT indicates that IRBIT should have a prominent role in the
regulation of epithelial HCO3− secretion. Indeed, knockdown of IRBIT markedly inhibited
pancreatic duct fluid and HCO3− secretion (458). Another important function of IRBIT is
coordination of the ductal secretory process by regulating the activity of CFTR at the
luminal membrane of the duct. Hence, IRBIT activates the native ductal CFTR and CFTR
expressed in model system by direct interaction with CFTR to increase CFTR open
probability (458). As was found with NBCe1-B, activation of CFTR by IRBIT is mediated
by the PEST domain and is aided by assembly of IRBIT-CFTR complexes through their
PDZ ligands (458). The findings in the native duct and with expressed NBCe1-B and CFTR
are summarized in the model in Fig. 5, illustrating how IRBIT coordinates epithelial fluid
and HCO3− secretion.
Activation of NBCe1-B and CFTR by IRBIT sets the ductal stimulated state of fluid and
HCO3− secretion. This raised the question of how the duct resting state is set and whether
IRBIT communicates with the regulators of the resting state. Inhibition of CFTR (455, 456)
and Slc26a6 (193, 325) by the WNK kinases prompted examining the role of the WNK/
SPAK kinases in the duct and their communication with IRBIT (456). As discussed above,
the first 120 N terminal residues of the WNKs upstream of the kinase domain function as
scaffolds (148, 155, 456) that recruit SPAK to NBCe1-B and CFTR. In turn, SPAK
phosphorylates NBCe1-B and CFTR to cause their endocytosis and inhibit ductal fluid and
HCO3− secretion (456). Significantly, IRBIT overrides the function of the WNK/SPAK
pathway by recruiting the phosphatase PP1 to dephosphorylate NBCe1-B and CFTR, insert
them into the basolateral and luminal membranes, respectively, and stimulate ductal fluid
and HCO3− secretion (456) (Figure 5).
As indicated above, another component of the duct resting state is HCO3− salvage by the
luminal NHE3 and NBCn1-A (233, 250). It is of note that other members of the Na+-driven
HCO3− transporters have an N terminal domain similar to that of NBCe1-B (35), including
the electroneutral NBCn1 and the Na+-dependent Cl−/HCO3− exchangers NDCBE. It is thus
possible that NBCn1, including the ductal NBCn1-A, are regulated by IRBIT, as was
suggested (35). However, it is not clear which NBCn1 and NDCBE isoforms are activated
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by IRBIT and whether IRBIT activate them by the same mechanism as NBCe1-B since the
N terminal domain of NBCe1-A~C, NBCn1-A~H and NDCBE-A~D differ substantially.
NHE3 was also reported to be modestly activated by IRBIT (149), which may be dependent
on Ca2+ (150). Interestingly, NHE3 (3) and NBCn1 (327) are inhibited by CFTR at the
luminal membrane. Hence, IRBIT appears to participate in the resting and stimulated state.
It is possible that in the resting state part of IRBIT is sequestered by IP3Rs and part of
IRBIT is associated with NHE3 and NBCn1-A to promote HCO3− salvage. Once the cells
are stimulated, IRBIT may dissociate from the HCO3− salvage, interact with the HCO3−
secretory transporters and stimulate ductal fluid and HCO3− secretion. The model in Figure
5 illustrates the multiple regulatory roles of IRBIT.
D. Carbonic Anydrases
A class of proteins essential for all HCO3− related functions is the carbonic anhydrases
(CAs). The global CA inhibitor acetazolamide significantly inhibits pancreatic (95, 321) and
minimally inhibit salivary (461) fluid and HCO3− secretion. Further studies revealed that
CAs are present at the HCO3− transporting complex, and supply HCO3− to several
transporters. The CAs physically interact with and regulate the activity of several HCO3−
transporters, including Na+-HCO3− co-transporters and the AE and SLC26A6 Cl−/HCO3−
exchangers (269). Immunolocalization suggested localization of CAII, CAIV, CAIX, and
CAXII in pancreatic (301) and multiple isoforms in salivary gland ducts (18, 172). Several
of the ductal Ca2+ signal are cytoplasmic and some are integral membrane proteins with the
catalytic domain in the cell surface. It is not clear at present which of these CAs is directly
coupled to the basolateral NBCe1-B and AE2 in the ducts. Interestingly, the trafficking of
CAIV to the luminal membrane is dependent on CFTR, and acetazolamide inhibits HCO3−
transport by SLC26A3 (102) and SLC26A6 (269). These findings imply the involvement of
the ductal CAs in HCO3− transport by the CFTR-SLC26Ts complex at the luminal
membrane.
VII. DISEASES OF DUCTAL HCO3− SECRETION
Altered fluid and HCO3− secretion is associated with several diseases that affect various
organs, although the pancreas is the most vulnerable to aberrant fluid and HCO3− secretion.
The best known of these diseases is CF (94). It is obvious why a lack of CFTR function
virtually eliminates ductal function. However, CF has a spectrum of phenotypes from mild
to very severe depending on the mutation and sometime even within the same mutation
(475), in particular in lung function (275). Interestingly, the CF genotype-phenotype
correlates best with the state of pancreatic function (375, 378). Examining several mutations
suggested that this relates to the ability of CFTR to support HCO3−, rather than Cl−,
transport (61), probably by stimulating the SLC26 transporters.
Another disease associated with aberrant HCO3− secretion is pancreatitis (70, 211, 409).
Pancreatitis is an inflammatory disease that results in destruction of the pancreas by toxins
that affect the acinar and duct cells (236). The most common form of pancreatitis is
alcoholic pancreatitis, although many other causes of pancreatitis are known (138, 322),
including autoimmune pancreatitis (211, 339). Most forms of pancreatitis are considered
idiopathic. The central role of CFTR in ductal function led to a search of CFTR mutations
associated with pancreatitis (63). The search identified several CFTR mutations that do not
result in any of the CF symptoms, but are associated with chronic pancreatitis (62, 63, 230).
Interestingly, recent analysis of two such mutations showed that they had no effect on Cl−
function of CFTR, but specifically reduced CFTR-mediated HCO3− transport (381, 436),
further emphasizing the importance of HCO3− secretion in ductal function.
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Of particular interest is a recent study that asked whether aberrant CFTR function is
associated with idiopathic forms of chronic pancreatitis (211). Patients with autoimmune
pancreatitis have reduced fluid and HCO3− secretion. Examination of CFTR localization in
pancreatic biopsies showed mislocalization of CFTR and its accumulation in intracellular
compartments (211). Most notably, treating the patients with corticosteroids corrected the
mislocalization of CFTR to restored pancreatic HCO3− secretion and ameliorates disease
severity (211). Moreover, preliminary results suggest that similar CFTR mislocalization
occurs in alcoholic pancreatitis (211). It will be of particular interest to further analyze
CFTR expression in all forms of pancreatitis, and if aberrant, whether correction of CFTR
localization reduce disease symptoms. In addition, it will be informative to determine the
fate of the SLC26 transporters in the disease, as they are tightly associated with CFTR
physically and functionally (214, 215).
Another autoimmune inflammatory disease in which HCO3− secretion by salivary glands is
aberrant is the dry-mouth, dry-eye disease Sjögren’s syndrome (7). The cause of the aberrant
HCO3− secretion is not known. However, one study reported that treating Sjögren’s
syndrome patients with the steroid prednisolone reduced damage and increased secretion by
salivary glands (279). The results of treating autoimmune pancreatitis with corticosteroids
(211) suggest that CFTR and perhaps the SLC26 transporters localization and/or function
are altered in Sjögren’s syndrome to reduce HCO3− secretion. Moreover, the reduced ductal
fluid and HCO3− secretion in two autoimmune inflammatory diseases raise the possibility
that many inflammatory diseases of secretory glands likely lead to some extent of reduced
ducal HCO3− secretion.
HCO3− secretion is also reduced in patients undergoing radiation treatment for head and
neck malignancies (7, 92). In this case it is likely that radiation resulted in ductal cell
damage. Radiation damage is most commonly associated with severe oxidative damage (2,
473). Hence, it is possible that other forms of oxidative damage cause reduced ductal
HCO3− secretion, in particular considering that CFTR activity is susceptible to oxidative
damage (385). Indeed, in rat and mouse models of bile acid-induced pancreatitis oxidative
stress causes marked reduction in ductal function that can be prevented by in vivo
stimulation of signaling pathways that reduced oxidative stress (290, 292). Analysis of
ductal transporters in these diseases should reveal the cause of the disease, suggest treatment
modalities, and further clarify the mechanism and regulation of ductal fluid and HCO3−
secretion.
VIII. MECHANISM AND A MODEL FOR DUCTAL HCO3− SECRETION
A. Basic Concepts
A unique feature of the duct in most species, including humans, is the secretion of copious
amount of HCO3− with the pancreatic duct secreting fluid containing as much as 140 mM
HCO3− (237). Accordingly, the mechanism and regulation of epithelial HCO3− secretion is
understood best in the pancreatic duct and thus the model we discuss reflects best the
mechanism of fluid and HCO3− secretion by the pancreatic duct. However, although not
understood at the same detail, the available data indicates that the mechanism discussed
below for the pancreatic duct is applicable to other exocrine gland ducts with variations that
meet specific glands specialization, but do not deviate from the basic principles, as we tried
to emphasis with the salivary gland ducts example.
The duct secretes most of the fluid in the pancreatic juice and while doing so it absorbs the
Cl− and secretes HCO3− to generate pancreatic juice containing about 20 mM Cl− and 140
mM HCO3−. This task imposes several criteria for the mechanism of pancreatic duct fluid
and HCO3− secretion that must be met. First, the basolateral HCO3− influx mechanism must
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be able to concentrate HCO3− in the duct cytosol. Second, HCO3− efflux mechanism at the
luminal membrane must be able to concentrate HCO3− at the luminal space and the luminal
membrane must have low HCO3− leak and maintain a membrane potential with negative
transcellular potential. While absorbing Cl− and secreting HCO3−, the pancreatic duct must
mediate large net transcellular salt transport necessary for copious fluid secretion by the
duct. Since the only osmolyte actively secreted by the pancreatic duct is HCO3−, the bulk of
HCO3− secretion cannot be by osmotically silent HCO3− transport mechanism, such as
coupled electroneutral 1Cl−/1HCO3− exchange or uncoupled 1Cl−/1HCO3− exchange by a
Cl− and HCO3− permeable channels, such as CFTR, or Cl− and K+ cotransport by luminal
Cl− and K+ channels. These set specific constrains on the basolateral HCO3− influx
mechanism and the luminal Cl− absorbing and HCO3− secreting mechanism. The capacity of
the basolateral HCO3− absorbing mechanism must exceed the capacity of basolateral HCO3−
efflux mechanisms, such as AE2, and the luminal HCO3− exit mechanism must function
with a stoichiometry of HCO3−/Cl− >1.
The first attempt to explain pancreatic duct fluid and HCO3− secretion was made in the late
1980’s by Argent and Case (14). The basic tenants of their model are the basolateral Na+/K+
pump and K+ channels, which generate the Na+ and K+ gradients and set the membrane
potential that are needed to fuel the secretion. A HCO3− entry equivalent is provided by
NHE. HCO3− then exits the luminal membrane by way of a Cl−/HCO3− exchange that
absorbs the Cl−, with the Cl− re-circulates by exiting through CFTR (14, 404). Although the
model does not meet the constraints listed above and thus cannot explain ductal fluid and
HCO3− secretion, it was an important model in drawing attention to the problem and
stimulating the study of ductal secretion.
Several key discoveries led to significant revision of this model. The major basolateral
HCO3− influx mechanism was identified as NBCe1-B, which functions as a 1Na+-2HCO3−
cotransporter (1, 180, 471). The main luminal Cl−/HCO3− exchanger in the pancreatic and
salivary ducts was identified as Slc26a6 (215, 247), which functions as electrogenic, coupled
1Cl−/2HCO3− exchanger (313, 388) that interacts with CFTR, with Slc26a6 and CFTR
activating each other (215). Modeling and studies in guinea pig pancreatic ducts suggested a
requirement for HCO3− channel activity to set the final pancreatic juice HCO3− at 140 mM
(400, 401, 437). These findings led a two stage model in which initially HCO3− is mediated
by electroneutral Cl−/HCO3− exchange. Higher HCO3− concentration in the pancreatic juice
is achieved by CFTR acting as a HCO3− channel (for review see (237, 404)). A significant
problem with the model is that it does not result in osmotic secretion of HCO3− and thus will
not lead to fluid secretion. In addition, the model does not explain how CFTR can conduct
HCO3− at the terminal portion of the duct.
B. A Model of Ductal Fluid and HCO3− Secretion
The following findings were used to develop the model in Fig. 6. Loss of pancreatic HCO3−
secretion in patients with CF (191) indicates that CFTR plays a critical role in HCO3−
secretion. The activity of the duct apical Cl−/HCO3− exchanger is inhibited by DIDS (235,
405) (which does not inhibit CFTR) and is dependent on the expression of CFTR (235, 238).
CFTR mutations associated with pancreatic insufficiency exhibit a severe defect in CFTR-
dependent Cl−/HCO3− exchange activity (61). Coupled or uncoupled, channel-mediated 1:1
Cl−/HCO3− exchange cannot account for either HCO3− or fluid secretion by the duct (154).
HCO3− secretion must be an osmotically active process. Electrogenic HCO3− transporters
can generate a fluid with high HCO3− concentrations using the driving force generated by
the negative luminal membrane potential. Apical Cl−/HCO3− exchanger by the duct is
electrogenic with distinct Cl−:HCO3− stoichiometry (215). The duct expresses Slc26a6 (214,
215) that functions as a 1Cl−/2HCO3− exchanger (313, 388). The WNK/SPAK pathway
stabilizes the resting state in the proximal portion of the duct (456), while regulating CFTR
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HCO3− selectivity and permeability in the distal portion of the duct, switching CFTR into a
HCO3−-selective channel (325). IRBIT governs ductal fluid and HCO3− secretion and
overrides the inhibitory action of the WNK/SPAK pathway (456). The findings lead to a two
stage model: In stage one the proximal duct secretes the bulk of fluid and HCO3− secretion
that is mediated by Slc26a6 with CFTR recycling the Cl−, the WNK/SPAK pathway
regulating the resting state and IRBIT set the stimulated state. In step two, the WNK/SPAK
pathway switches CFTR to largely a HCO3− channel to secret HCO3− and set the final
HCO3− secretion of the pancreatic juice (Fig. 6).
With the steep inward Na+ gradient of about 15 fold, 1Na+-2HCO3− co-transport by NBCe1-
B leads to active accumulation of cytosolic HCO3−. Secretion of HCO3− by the 1Cl−/
2HCO3− exchanger Slc26a6 leads to osmotic secretion of HCO3−. The obligatory movement
of Na+ through the paracellular pathway results in net Na+-HCO3− secretion that drives
water efflux by AQP1 and starts the process of accumulation of HCO3− in the duct lumen.
In the resting state, the WNK/SPAK pathway keeps large fraction of NBCe1-B and of CFTR
in intracellular compartments while IRBIT may be associated with and activate NHE3 and
NBCn1-A (not included in the model) to salvage any Na+ and HCO3− leaking to the duct
lumen. Initiation of ductal secretion requires antagonism of the WNK/SPAK pathway by
IRBIT-mediated recruitment of PP1 to dephosphorylate the transporters NBCe1-B and
CFTR and exocytose them to their respective plasma membrane. Once at the plasma
membrane the transporters are phosphorylated by PKA and now IRBIT interacts directly
with the inhibitory domains in NBCe1-B, CFTR and perhaps Slc26a6 to activate them and
set the stimulated state. At a luminal membrane potential of −50 mV or more negative, and
the ionic gradients of HCO3− and Cl− set by NBCe1-B and CFTR, 1Cl−: 2HCO3− exchange
by Slc26a6 can achieve a luminal HCO3− concentration of about 136 mM (404).
To transport events in the proximal duct outlined above can account for the bulk of fluid and
HCO3− secretion by the rodent duct. However, the guinea pig, pig and human pancreatic
ducts can generate pancreatic juice containing more than 120–130 mM HCO3−. As luminal
Cl− is absorbed, the reduced Cl− gradient across the luminal membrane limits HCO3−
secretion by Slc26a6, and thus alternative pathway if HCO3− efflux is required to maintain
HCO3− secretion. The decrease in luminal Cl− and the activated CFTR at a membrane
potential of −50 mV or more negative reduces [Cl−]i to below 10 mM, which serves as an
alternative signal to modulate the activity of WNK/SPAK pathway. Activation of the WNK/
SPAK pathway by low [Cl−]i converts CFTR from a Cl− channel to preferably HCO3−
channel, allowing further HCO3− efflux. The WNK/SPAK pathway inhibits any luminal
Cl−/HCO3− exchange activity to avoid HCO3− absorption due to the steep HCO3− gradient
set by CFTR (325). IRBIT activity in this portion of the duct needs to be reduced (not
included in the model), to allow the WNK/SPAK pathway to act on CFTR and the SLC26
transporters.
The model in Fig. 6 can explains the available information on the mechanism of fluid and
HCO3− secretion by secretory gland ducts, most importantly how the duct can secrete both
large fluid volume and high amount of HCO3−. By no means, this intent to be the last word
in the mechanism by which secretory gland ducts secrete fluid and electrolytes. As with
other models, including our earlier models, it will continue to evolve as knowledge of
existing pathway increases and new pathways are discovered. However, we hope that at this
stage the model will stimulate further research into this so very important topic of fluid and
HCO3− secretion that is aberrant in large number of epithelial diseases.
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Fig. 1. The acinar and ductal segments of secretory glands and fluid and electrolyte secretory
functions
The figure illustrates the relationships between the acinar and ductal portion of secretory
glands. The acini secrete isotonic fluid with NaCl as the major salt. The fluid passes through
the centroacinar cells to the duct. The pancreatic duct absorbs the Cl− and secretes HCO3−
and most of the water in the pancreatic juice. Active HCO3− secretion drives fluid secretion.
The salivary duct absorbs both the Cl− and the Na+ and secretes HCO3− and K+. ENaC is
expressed in the salivary glands, but not in the pancreatic duct, and is the main pathway for
Na+ absorption by the salivary glands duct.
Lee et al. Page 54
Physiol Rev. Author manuscript; available in PMC 2013 May 30.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Fig. 2. A model depicting the mechanism of acinar cells fluid and electrolyte secretion
Shown are the major transporters in the basolateral and luminal membranes of acinar cells
and their regulation. The major Cl− loading transporter at the basolateral membrane is
NKCC1, with part of the Cl− loading (about 30%) provided by the parallel functioning of
NHE1 and AE2. The membrane potential is determined by two Ca2+-activated K+ channels,
the MaxiK and mIK1 channels. TMAM16a/Ano1 is the major Ca2+-activated Cl− channel at
the luminal membrane that also expresses the water channel AQP5. Fluid and electrolyte
secretion by acinar cells is regulated by Ca2+-mobilizing receptors and is a Cl− secretion-
driven process. The receptor-evoked [Ca2+]i increase initiates at the apical pole where the
Ca2+ signaling complexes are located to activate TMEM16a/Ano1. The Ca2+ signal then
propagates to the basal pole to activate the K+ channels. The Ca2+-mediated channels
activation results in luminal Cl− efflux and basolateral K+ efflux. Na+ then flows through the
tight junction to the luminal space. The secretion of NaCl leads to water efflux through
AQP5 and cell shrinkage. Cell shrinkage reduces [Ca2+]i to inhibit the Cl− and K+ channels
and at the same time activates the volume-sensitive NKCC1 (and NHE1 and AE2) to restore
cell Cl− and K+. The cycle repeats itself during each spike of Ca2+ oscillations.
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Fig. 3. A model depicting the mechanism of ductal fluid and HCO3− secretion
Shown are the major transporters in the basolateral and luminal membranes of duct cells. In
the pancreas ductal secretion is driven by HCO3− secretion. The major HCO3− loading
mechanism is the basolateral Na+-HCO3− cotransporter NBCe1-B. Luminal HCO3−
secretion is mediated by the CFTR-Slc26a6 complex. The duct also expresses the HCO3−
salvage mechanisms NHE3 and NBCn1-A. The salivary glands, but not the pancreatic, duct
also expresses ENaC at the luminal membrane. The functioning of the transporters in ductal
fluid and HCO3− secretion is illustrated in Fig. 6.
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Fig. 4. Ductal proteins with PDZ ligands that participate in fluid and HCO3− secretion
All receptors that stimulate ductal secretion and key transporters that mediate ductal fluid
and HCO3− secretion have PDZ ligands, highlighting the key role of PDZ scaffolds in ductal
function. See text for details.
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Fig. 5. The IRBIT/PP1 and WNK/SPAK pathways in ductal function
IRBIT is a key regulator of ductal fluid and HCO3− secretion that regulates both the resting
and stimulated states of ductal secretion. PZD scaffolds assemble a basolateral membrane
complex composed of NBCe1-B, the WNK/SPAK kinases and IRBIT (which can recruit the
phosphatase PP1 to the complex). Similar complex exists in the luminal membrane with
CFTR and perhaps Slc26a6 as the major transporters. In the resting state the WNK/SPAK
kinases phosphorylate all transporters to reduce their surface expression and thus activity.
Part of IRBIT is sequestered by IP3Rs and part is bound to NHE3 and NBCn1-A to activate
them and thus affect HCO3− salvage. Upon cell stimulation IRBIT recruits PP1 to the
complexes, which overrides the function of the WNK/SPAK pathway and dephosphorylates
the HCO3− secreting transporters to increase their surface expression. IRBIT then binds and
neutralizes the effect of the HCO3− secreting transporters inhibitory domains. The combined
effects stabilize the secretory state of the duct. The mutual stimulation of CFTR and Slc26a6
in the complex further augments ductal secretion.
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Fig. 6. A model of pancreatic duct fluid and HCO3− secretion
Ductal fluid and HCO3− secretion is a two stage process. In the proximal duct IRBIT
antagonizes the effect of the WNK/SPAK pathway to stimulate ductal secretion. HCO3−
accumulates in the duct cytosol by NBCe1-B and exits into the lumen mostly by Slc26a6,
which mediates 1Cl−/2HCO3− exchange, with CFTR recycling the Cl−. This result with
osmotic secretion of HCO3− and together with transcellular Na+ fluxes through the
paracellular pathway drives fluid secretion. The water is secreted by AQP1. The proximal
duct thus absorbs part of the Cl− and secretes as much as 100 mM HCO3− to secret large
fraction of the fluid in the pancreatic juice. As the fluid arrives the more distal portions of
the duct, the reduced luminal Cl− and activated CFTR results in intracellular Cl−
concentration ([Cl−]i) of less than 10 mM. The low [Cl−]i activates WNK1 that
phosphorylates SPAK/OSP1, which, in turn, acts on CFTR to change its Cl−/HCO3−
selectivity, converting it primarily a HCO3− channel. At the same time the WNK/SPAK
pathway inhibits the function of Slc26a6 to prevent HCO3− re-absorption. HCO3− efflux by
CFTR thus determines the final HCO3− concentration in the secreted fluid.
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